<?xml version="1.0" encoding="UTF-8" ?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:media="http://search.yahoo.com/mrss/">
    <channel>
        <title>ABPI Blogs and News</title>
        <description>ABPI Blogs and News</description>
        <link>https://www.abpi.org.uk/media/</link>  
        <atom:link href="https://www.abpi.org.uk/feed/" rel="self" type="application/rss+xml" />
        <lastBuildDate>Thu, 06 Aug 2026 10:40:20 GMT</lastBuildDate>
        <language>en-gb</language>
                <item>
                    <title>Why the government must urgently raise the NICE cost-effectiveness threshold</title>
<link>https://www.abpi.org.uk/media/blogs/2025/october/why-the-government-must-urgently-raise-the-nice-cost-effectiveness-threshold/</link>                    <pubDate>Thu, 06 Aug 2026 10:40:20 GMT</pubDate>
                            <dc:creator><![CDATA[Victoria Jordan]]></dc:creator>
                            <category><![CDATA[NICE]]></category>
                            <category><![CDATA[Pricing]]></category>
                            <category><![CDATA[Access]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2025/october/why-the-government-must-urgently-raise-the-nice-cost-effectiveness-threshold/</guid>
                    <description><![CDATA[In this piece, Victoria Jordan, ABPI&#x27;s Director, Value and Access Policy, explains why the government must increase NICE&#x2019;s baseline threshold to ensure that NHS patients benefit from timely access to the latest treatments.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/00kl03qg/nursesl-871x581.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d9da41cdfdc4f0"/>
                </item>
                <item>
                    <title>International comparisons in medicines spending and the link to competitiveness</title>
<link>https://www.abpi.org.uk/media/blogs/2025/october/international-comparisons-in-medicines-spending-and-the-link-to-competitiveness/</link>                    <pubDate>Thu, 06 Aug 2026 10:38:45 GMT</pubDate>
                            <category><![CDATA[Pricing]]></category>
                            <category><![CDATA[Access]]></category>
                            <category><![CDATA[VPAG]]></category>
                            <category><![CDATA[VPAG (1)]]></category>
                            <category><![CDATA[Voluntary Scheme]]></category>
                            <category><![CDATA[Voluntary Scheme News]]></category>
                            <category><![CDATA[Statutory Scheme]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2025/october/international-comparisons-in-medicines-spending-and-the-link-to-competitiveness/</guid>
                    <description><![CDATA[Kim Assender, Director of Commercial Policy and Analysis at the ABPI, discusses a new report from IQVIA and what it says about the right strategic level of spending on medicines to deliver the best outcomes for patients while supporting cash-strapped health systems and delivering wider economic growth.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/ilxj4h3y/glove-vial-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef087fd0"/>
                </item>
                <item>
                    <title>Laura McMullin of Daiichi Sankyo named as new ABPI Vice-President</title>
<link>https://www.abpi.org.uk/media/news/2025/july/laura-mcmullin-of-daiichi-sankyo-named-as-new-abpi-vice-president/</link>                    <pubDate>Thu, 06 Aug 2026 10:36:46 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/july/laura-mcmullin-of-daiichi-sankyo-named-as-new-abpi-vice-president/</guid>
                    <description><![CDATA[The ABPI has appointed Laura McMullin as Vice-President of the ABPI. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/zd4nk3hm/laura_mcmullin.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1dc168b111caf30"/>
                </item>
                <item>
                    <title>Growth and skills levy: A catalyst for the UK pharmaceutical industry?</title>
<link>https://www.abpi.org.uk/media/blogs/2025/february/growth-and-skills-levy-a-catalyst-for-the-uk-pharmaceutical-industry/</link>                    <pubDate>Thu, 06 Aug 2026 10:35:18 GMT</pubDate>
                            <dc:creator><![CDATA[Oliver Buckley-Mellor]]></dc:creator>
                            <category><![CDATA[Apprentices]]></category>
                            <category><![CDATA[Skills]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2025/february/growth-and-skills-levy-a-catalyst-for-the-uk-pharmaceutical-industry/</guid>
                    <description><![CDATA[This blog explores how the government&#x2019;s Growth and Skills Levy can help to achieve this ambition by making education and training more accessible while building on the success of apprenticeships in the life sciences sector]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/i3qllhte/biology-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52f0316f70"/>
                </item>
                <item>
                    <title>Gen Z are turning to TikTok for career advice and inspiration, finds new report</title>
<link>https://www.abpi.org.uk/media/news/2025/june/gen-z-are-turning-to-tiktok-for-career-advice-and-inspiration-finds-new-report/</link>                    <pubDate>Thu, 06 Aug 2026 10:31:57 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Education]]></category>
                            <category><![CDATA[ABPI Schools]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/june/gen-z-are-turning-to-tiktok-for-career-advice-and-inspiration-finds-new-report/</guid>
                    <description><![CDATA[Employers looking to attract young talent into life sciences careers must embrace authenticity and social media channels, according to a new report.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/fdzf5j0f/gen-z-report-image.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1dbd52f30f05e80"/>
                </item>
                <item>
                    <title>Reinventing Reputation: one of pharma&#x27;s biggest challenges</title>
<link>https://www.abpi.org.uk/media/blogs/2024/january/reinventing-reputation-one-of-pharmas-biggest-challenges/</link>                    <pubDate>Thu, 06 Aug 2026 10:25:13 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Reputation]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2024/january/reinventing-reputation-one-of-pharmas-biggest-challenges/</guid>
                    <description><![CDATA[Blog post by Seyda Atadan Memis, Takeda General Manager UK &amp; Ireland and ABPI Reputation Board Sponsor]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/fllbhtqp/239_cm307191_abpi-reputation-event.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1da4d4bb5121cc0"/>
                </item>
                <item>
                    <title>ABPI respond to Wes Streeting&#x2019;s commitment to boosting the economy through the life sciences sector</title>
<link>https://www.abpi.org.uk/media/news/2024/july/abpi-respond-to-wes-streeting-s-commitment-to-boosting-the-economy-through-the-life-sciences-sector/</link>                    <pubDate>Thu, 06 Aug 2026 10:23:54 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/july/abpi-respond-to-wes-streeting-s-commitment-to-boosting-the-economy-through-the-life-sciences-sector/</guid>
                    <description><![CDATA[Wes Streeting commits to boosting the economy through the life sciences sector]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/iogneyoy/image-12.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1dad20842a8a1d0"/>
                </item>
                <item>
                    <title>ABPI welcomes Labour&#x27;s life sciences plan</title>
<link>https://www.abpi.org.uk/media/news/2024/january/abpi-welcomes-labours-life-sciences-plan/</link>                    <pubDate>Thu, 06 Aug 2026 10:21:38 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Research and Development]]></category>
                            <category><![CDATA[Clinical research]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/january/abpi-welcomes-labours-life-sciences-plan/</guid>
                    <description><![CDATA[The Labour party has today published its plan for life sciences, aimed at transforming how medical treatments are discovered and delivered.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/fh4edk5k/events-930x930-production-worker-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ee9376e0"/>
                </item>
                <item>
                    <title>Understanding NHS medicines spending in England</title>
<link>https://www.abpi.org.uk/media/blogs/2025/march/understanding-nhs-medicines-spending-in-england/</link>                    <pubDate>Thu, 06 Aug 2026 10:16:42 GMT</pubDate>
                            <dc:creator><![CDATA[Pinchas Kahtan]]></dc:creator>
                            <category><![CDATA[Access]]></category>
                            <category><![CDATA[Medicines sales]]></category>
                            <category><![CDATA[Pricing]]></category>
                            <category><![CDATA[Value]]></category>
                            <category><![CDATA[Voluntary Scheme]]></category>
                            <category><![CDATA[Voluntary Scheme News]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2025/march/understanding-nhs-medicines-spending-in-england/</guid>
                    <description><![CDATA[This article discusses what the NHS Business Services Authority (BSA) data can tell us about NHS medicine spending and how industry payments shape the true level of NHS spending on medicines. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/jgrn2v23/data-woman-explain-871x581.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef712cb0"/>
                </item>
                <item>
                    <title>ABPI response to the Budget</title>
<link>https://www.abpi.org.uk/media/news/2024/march/abpi-response-to-the-budget/</link>                    <pubDate>Wed, 05 Aug 2026 17:40:47 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Budget]]></category>
                            <category><![CDATA[Manufacturing]]></category>
                            <category><![CDATA[Economy and Industry]]></category>
                            <category><![CDATA[Life Sciences]]></category>
                            <category><![CDATA[Politics]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/march/abpi-response-to-the-budget/</guid>
                    <description><![CDATA[The Association of the British Pharmaceutical Industry (ABPI) has welcomed measures in Chancellor Jeremy Hunt&#x2019;s Budget to unlock investment in medical research and medicines manufacturing, and improve NHS productivity. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/4ynexl2a/clinical-data-management-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52f061ce40"/>
                </item>
                <item>
                    <title>UK must get ready for new cell and gene therapies, says ABPI</title>
<link>https://www.abpi.org.uk/media/news/2024/august/uk-must-get-ready-for-new-cell-and-gene-therapies-says-abpi/</link>                    <pubDate>Wed, 05 Aug 2026 17:36:31 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[ATMP]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/august/uk-must-get-ready-for-new-cell-and-gene-therapies-says-abpi/</guid>
                    <description><![CDATA[The NHS got off to a good start with the introduction of cell and gene therapies but must do more to prepare for future advanced therapies.  ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/jcgofh1n/women-scientist-microscope-871x581-webp75.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef19bde0"/>
                </item>
                <item>
                    <title>BioNTech&#x2019;s investment provides a template for UK growth, say ABPI</title>
<link>https://www.abpi.org.uk/media/news/2025/may/biontech-s-investment-provides-a-template-for-uk-growth-say-abpi/</link>                    <pubDate>Wed, 05 Aug 2026 17:32:05 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Clinical research]]></category>
                            <category><![CDATA[Economy and Industry]]></category>
                            <category><![CDATA[Life Sciences]]></category>
                            <category><![CDATA[Science and innovation]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/may/biontech-s-investment-provides-a-template-for-uk-growth-say-abpi/</guid>
                    <description><![CDATA[The innovative biopharmaceutical company BioNTech has announced a major investment of up to &#xA3;1bn over 10 years in the UK, potentially creating more than 400 new jobs in London and Cambridge.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/ra2leyup/scientists-lab-871x581.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c9812ef1ef0"/>
                </item>
                <item>
                    <title>Making Wales a destination for industry clinical trials and medical research</title>
<link>https://www.abpi.org.uk/media/blogs/2025/september/making-wales-a-destination-for-industry-clinical-trials-and-medical-research/</link>                    <pubDate>Wed, 05 Aug 2026 17:30:13 GMT</pubDate>
                            <category><![CDATA[Wales]]></category>
                            <category><![CDATA[Devolved Nations - Cymru Wales]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2025/september/making-wales-a-destination-for-industry-clinical-trials-and-medical-research/</guid>
                    <description><![CDATA[Clinical trials are at the heart of developing new medicines and vaccines. They offer the opportunity for patients to receive early access to potentially lifesaving treatments and deliver huge benefits to both the NHS and the wider economy. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/wwfhwapd/senedd-968x457-banner.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1dacb90127a1210"/>
                </item>
                <item>
                    <title>New data shows UK life sciences failing to reach its potential</title>
<link>https://www.abpi.org.uk/media/news/2024/july/new-data-shows-uk-life-sciences-failing-to-reach-its-potential/</link>                    <pubDate>Wed, 05 Aug 2026 17:23:49 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/july/new-data-shows-uk-life-sciences-failing-to-reach-its-potential/</guid>
                    <description><![CDATA[New data on the &#x2018;Life sciences competitiveness indicators 2024&#x2019;, published by the government&#x2019;s Office for Life Sciences.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/riwf5xcq/quality-control-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eff577e0"/>
                </item>
                <item>
                    <title>Unlocking the East of England&#x2019;s life sciences potential: Reflections from our regional roundtable</title>
<link>https://www.abpi.org.uk/media/blogs/2026/july/unlocking-the-east-of-england-s-life-sciences-potential-reflections-from-our-regional-roundtable/</link>                    <pubDate>Fri, 31 Jul 2026 08:29:55 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2026/july/unlocking-the-east-of-england-s-life-sciences-potential-reflections-from-our-regional-roundtable/</guid>
                    <description><![CDATA[How do we ensure regions like the East of England have the right conditions to drive the next phase of UK life sciences growth?]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/ksbmf5m1/plans2-871x581.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d9da41ce298fe0"/>
                </item>
                <item>
                    <title>Calls for collaboration on medical research in Wales</title>
<link>https://www.abpi.org.uk/media/news/2024/july/calls-for-collaboration-on-medical-research-in-wales/</link>                    <pubDate>Thu, 30 Jul 2026 11:51:40 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Devolved Nations - Cymru Wales]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/july/calls-for-collaboration-on-medical-research-in-wales/</guid>
                    <description><![CDATA[ABPI Cymru and the British Heart Foundation (BHF) Cymru call for prioritisation of medical research funding in Wales.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/wiuabwgs/sennedd-2522x722-banner.jpg?rxy=0.3629310026155884,0.4863656195462478&amp;width=240&amp;height=135&amp;quality=90&amp;v=1dacd3655fdb7b0"/>
                </item>
                <item>
                    <title>ABPI comment on resignation of Lord Vallance</title>
<link>https://www.abpi.org.uk/media/news/2026/july/abpi-comment-on-resignation-of-lord-vallance/</link>                    <pubDate>Mon, 20 Jul 2026 12:35:48 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Politics]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2026/july/abpi-comment-on-resignation-of-lord-vallance/</guid>
                    <description><![CDATA[On the resignation of Lord Vallance as Science Minister, Richard Torbett, Chief Executive of the ABPI, said: &#xA;&#xA;&#x201C;Patrick Vallance has been a tremendous Science Minister and a genuine champion for the UK&#x27;s life sciences sector. He has been instrumental in beginning to turn around international sentiment towards the UK as a life sciences destination. On behalf of the industry, I want to thank him for his leadership and his willingness to engage directly and constructively with me and with our sector throughout his time in office. He leaves big shoes to fill.&#xA;&#xA;&quot;I look forward to working with whoever the new Prime Minister appoints to this critical role, and to continuing to build on the momentum needed to deliver the real growth and investment potential of UK life sciences.&quot;&#xA;]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/0mgjexoi/mps-2-871x581.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d9da41cdf42800"/>
                </item>
                <item>
                    <title>New map shows how pharmaceuticals support jobs, health and growth across every UK nation</title>
<link>https://www.abpi.org.uk/media/news/2026/july/new-map-shows-how-pharmaceuticals-support-jobs-health-and-growth-across-every-uk-nation/</link>                    <pubDate>Tue, 14 Jul 2026 10:55:59 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2026/july/new-map-shows-how-pharmaceuticals-support-jobs-health-and-growth-across-every-uk-nation/</guid>
                    <description><![CDATA[The Association of the British Pharmaceutical Industry (ABPI) has launched an updated interactive resource showing the contribution the pharmaceutical industry makes to health, jobs, research and economic growth across all four UK nations.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/n1wloltd/sector-insights-map-871x581.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d9a4f2fc5e0000"/>
                </item>
                <item>
                    <title>Why cross-sector collaboration in AI is the key to unlocking new medicines</title>
<link>https://www.abpi.org.uk/media/blogs/2026/july/why-cross-sector-collaboration-in-ai-is-the-key-to-unlocking-new-medicines/</link>                    <pubDate>Tue, 14 Jul 2026 09:06:35 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Health data]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2026/july/why-cross-sector-collaboration-in-ai-is-the-key-to-unlocking-new-medicines/</guid>
                    <description><![CDATA[While not a silver bullet, AI focuses research efforts on the most promising compounds with the highest likelihood of clinical success.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/esfh3wzz/scientist-microscope-2026-871x581.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1dd0316fe6049f0"/>
                </item>
                <item>
                    <title>Package deals in the pharmaceutical industry and Disclosure UK data</title>
<link>https://www.abpi.org.uk/media/blogs/2026/june/package-deals-in-the-pharmaceutical-industry-and-disclosure-uk-data/</link>                    <pubDate>Tue, 07 Jul 2026 14:28:38 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2026/june/package-deals-in-the-pharmaceutical-industry-and-disclosure-uk-data/</guid>
                    <description><![CDATA[Alex Fell, Chief Executive at the PMCPA, talks about package deals in the pharmaceutical industry and why guidance from the Prescription Medicines Code of Practice Authority (PMCPA) on package deals may have contributed to an increase in &#x2018;contracted services&#x2019; reported spend in disclosure data.  ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/wbsly1i1/disclosure-doctor-green-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef6ebbb0"/>
                </item>
                <item>
                    <title>Disclosure UK 2025: the 11th year of Disclosure UK data, with industry transparency continuing to grow</title>
<link>https://www.abpi.org.uk/media/blogs/2026/june/disclosure-uk-2025-the-11th-year-of-disclosure-uk-data-with-industry-transparency-continuing-to-grow/</link>                    <pubDate>Tue, 07 Jul 2026 14:28:38 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2026/june/disclosure-uk-2025-the-11th-year-of-disclosure-uk-data-with-industry-transparency-continuing-to-grow/</guid>
                    <description><![CDATA[Dr Amit Aggarwal, ABPI Executive Director of Medical Affairs and Strategic Partnerships, and Alex Fell, PMCPA Chief Executive, discuss the latest data published on Disclosure UK, the industry database which records payments and benefits in kind from pharmaceutical companies to NHS and other healthcare organisations and healthcare professionals.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/ywhfvcch/detail-2026-871x581_working-together.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1dc94282c94e370"/>
                </item>
                <item>
                    <title>Updates to the NHS Commercial Framework must deliver more flexibility to support timely access to medicines</title>
<link>https://www.abpi.org.uk/media/blogs/2025/february/updates-to-the-nhs-commercial-framework-must-deliver-more-flexibility-to-support-timely-access-to-medicines/</link>                    <pubDate>Tue, 07 Jul 2026 14:28:38 GMT</pubDate>
                            <dc:creator><![CDATA[Victoria Jordan]]></dc:creator>
                            <category><![CDATA[Access]]></category>
                            <category><![CDATA[Advanced Therapy Medicinal Products (ATMPs)]]></category>
                            <category><![CDATA[ATMP]]></category>
                            <category><![CDATA[Health and Access to Medicines]]></category>
                            <category><![CDATA[NHS Commercial Framework for New Medicines]]></category>
                            <category><![CDATA[NICE]]></category>
                            <category><![CDATA[NICE Methods Review]]></category>
                            <category><![CDATA[Pricing]]></category>
                            <category><![CDATA[Value]]></category>
                            <category><![CDATA[Voluntary Scheme]]></category>
                            <category><![CDATA[Voluntary Scheme News]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2025/february/updates-to-the-nhs-commercial-framework-must-deliver-more-flexibility-to-support-timely-access-to-medicines/</guid>
                    <description><![CDATA[NHS England (NHSE) has published an update to the commercial framework for new medicines. In this article, Victoria Jordan, ABPI&#x2019;s Director of Value and Access Policy, reflects on what has been achieved and what must be prioritised as phase two of the consultation approaches.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/pgwagn03/doctor-patient-bedside-871x581-web75.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eefc4ad0"/>
                </item>
                <item>
                    <title>Greater ambition is needed to improve patient access to innovative medicines</title>
<link>https://www.abpi.org.uk/media/blogs/2024/december/greater-ambition-is-needed-to-improve-patient-access-to-innovative-medicines/</link>                    <pubDate>Tue, 07 Jul 2026 14:28:37 GMT</pubDate>
                            <dc:creator><![CDATA[Paul Catchpole]]></dc:creator>
                            <category><![CDATA[Access]]></category>
                            <category><![CDATA[Advanced Therapy Medicinal Products (ATMPs)]]></category>
                            <category><![CDATA[ATMP]]></category>
                            <category><![CDATA[Health and Access to Medicines]]></category>
                            <category><![CDATA[NHS Commercial Framework for New Medicines]]></category>
                            <category><![CDATA[NICE]]></category>
                            <category><![CDATA[Value]]></category>
                            <category><![CDATA[Voluntary Scheme]]></category>
                            <category><![CDATA[Voluntary Scheme News]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2024/december/greater-ambition-is-needed-to-improve-patient-access-to-innovative-medicines/</guid>
                    <description><![CDATA[The government is consulting on changes to the Commercial Framework for New Medicines and the Budget Impact Test threshold. In this article, Paul Catchpole, ABPI&#x2019;s Director of Value and Access Policy, sets out why this is important and what needs to change.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/00kl03qg/nursesl-871x581.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d9da41cdfdc4f0"/>
                </item>
                <item>
                    <title>Improved early warning systems needed to reduce medicines supply risks, says ABPI</title>
<link>https://www.abpi.org.uk/media/news/2026/may/improved-early-warning-systems-needed-to-reduce-medicines-supply-risks-says-abpi/</link>                    <pubDate>Mon, 06 Jul 2026 13:25:28 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2026/may/improved-early-warning-systems-needed-to-reduce-medicines-supply-risks-says-abpi/</guid>
                    <description><![CDATA[A new report from the Association of the British Pharmaceutical Industry sets out the leading causes of medicine supply shocks, alongside a plan to further strengthen UK medicines supply chains to protect patients when disruptions occur.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/dbhj0cp5/pexels-tom-fisk-3063470.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1da27881f8f4710"/>
                </item>
                <item>
                    <title>ABPI celebrates a month of major investment commitments into UK life sciences</title>
<link>https://www.abpi.org.uk/media/news/2026/april/abpi-celebrates-a-month-of-major-investment-commitments-into-uk-life-sciences/</link>                    <pubDate>Mon, 06 Jul 2026 13:24:40 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Health and Access to Medicines]]></category>
                            <category><![CDATA[Life Sciences]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2026/april/abpi-celebrates-a-month-of-major-investment-commitments-into-uk-life-sciences/</guid>
                    <description><![CDATA[Following two new major investments in UK life sciences in April - &#xA3;300 million by AstraZeneca, and &#xA3;150 million by Boehringer Ingelheim - the ABPI points to the real progress unlocked by the landmark UK-U.S. Pharmaceutical arrangement.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/u1ipbvtg/toxicology-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52f03b3370"/>
                </item>
                <item>
                    <title>The UK should seek to be a European leader for rare disease medicine, says new report</title>
<link>https://www.abpi.org.uk/media/news/2026/april/the-uk-should-seek-to-be-a-european-leader-for-rare-disease-medicine-says-new-report/</link>                    <pubDate>Mon, 06 Jul 2026 13:24:23 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Rare diseases]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2026/april/the-uk-should-seek-to-be-a-european-leader-for-rare-disease-medicine-says-new-report/</guid>
                    <description><![CDATA[Improving NHS access to innovative rare disease treatments could generate &#xA3;19 billion in productivity gains over 10 years.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/m2zhbrml/fingers-vial-blue-871x581.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef6c23a0"/>
                </item>
                <item>
                    <title>Life Sciences Sector Policy Delivery</title>
<link>https://www.abpi.org.uk/media/news/2026/march/life-sciences-sector-policy-delivery/</link>                    <pubDate>Mon, 06 Jul 2026 13:24:11 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Medicines pricing]]></category>
                            <category><![CDATA[Pricing]]></category>
                            <category><![CDATA[Access]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2026/march/life-sciences-sector-policy-delivery/</guid>
                    <description><![CDATA[The government and the UK life sciences industry have launched a Joint Taskforce to drive innovation in the UK&#x2019;s commercial environment for medicines. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/zbkfg4k4/sales-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52efd14e10"/>
                </item>
                <item>
                    <title>Unlocking NHS data to increase recruitment into clinical trials will give the UK a competitive edge, says ABPI</title>
<link>https://www.abpi.org.uk/media/news/2026/march/unlocking-nhs-data-to-increase-recruitment-into-clinical-trials-will-give-the-uk-a-competitive-edge-says-abpi/</link>                    <pubDate>Mon, 06 Jul 2026 13:23:56 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Clinical research]]></category>
                            <category><![CDATA[Health data]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2026/march/unlocking-nhs-data-to-increase-recruitment-into-clinical-trials-will-give-the-uk-a-competitive-edge-says-abpi/</guid>
                    <description><![CDATA[The UK has an opportunity to enhance its global competitiveness in the delivery of industry clinical trials by harnessing NHS health data to more efficiently recruit patients, according to a new report from the ABPI.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/chxbqmn1/doctor-examining-patient-2025-871x581.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1dc5d1b9c8c1ac0"/>
                </item>
                <item>
                    <title>ABPI response to publication of England&#x27;s Rare Diseases Action Plan 2026</title>
<link>https://www.abpi.org.uk/media/news/2026/february/abpi-response-to-publication-of-englands-rare-diseases-action-plan-2026/</link>                    <pubDate>Mon, 06 Jul 2026 13:23:45 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Rare diseases]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2026/february/abpi-response-to-publication-of-englands-rare-diseases-action-plan-2026/</guid>
                    <description><![CDATA[The ABPI has responded to England&#x27;s latest Rare Diseases Action Plan, published in advance of Rare Disease Day. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/dkmh2k31/microscope-laptop-580x405-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eec7cd50"/>
                </item>
                <item>
                    <title>New report underlines the health and economic opportunity from boosting industry clinical trials</title>
<link>https://www.abpi.org.uk/media/news/2026/february/new-report-underlines-the-health-and-economic-opportunity-from-boosting-industry-clinical-trials/</link>                    <pubDate>Mon, 06 Jul 2026 13:23:34 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2026/february/new-report-underlines-the-health-and-economic-opportunity-from-boosting-industry-clinical-trials/</guid>
                    <description><![CDATA[A new EFPIA report highlights the significant health, economic and productivity returns that would result from increasing clinical trial activity across Europe.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/smlloguk/petri-dish-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ee483d10"/>
                </item>
                <item>
                    <title>ABPI comment on measles outbreak and childhood vaccination</title>
<link>https://www.abpi.org.uk/media/news/2026/february/abpi-comment-on-measles-outbreak-and-childhood-vaccination/</link>                    <pubDate>Mon, 06 Jul 2026 13:23:22 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Vaccines]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2026/february/abpi-comment-on-measles-outbreak-and-childhood-vaccination/</guid>
                    <description><![CDATA[The ABPI&#x27;s comment on the measles outbreak in North London, highlighting the importance of vaccination. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/aebpbmh5/vials-spin-blue-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef3de7b0"/>
                </item>
                <item>
                    <title>UK opportunity to accelerate development of new medicines</title>
<link>https://www.abpi.org.uk/media/news/2026/february/uk-opportunity-to-accelerate-development-of-new-medicines/</link>                    <pubDate>Mon, 06 Jul 2026 13:23:00 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2026/february/uk-opportunity-to-accelerate-development-of-new-medicines/</guid>
                    <description><![CDATA[New report shows a coordinated approach needed to so academic discoveries can be taken forward with industry to develop new treatments.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/pq3fnuvz/scientist-pipetting-580x405-webp75.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ee960ef0"/>
                </item>
                <item>
                    <title>ABPI response to National Cancer Plan</title>
<link>https://www.abpi.org.uk/media/news/2026/february/abpi-response-to-national-cancer-plan/</link>                    <pubDate>Mon, 06 Jul 2026 13:22:49 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Cancer]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2026/february/abpi-response-to-national-cancer-plan/</guid>
                    <description><![CDATA[The government has published its National Cancer Plan, outlining how it intends to transform cancer care and outcomes in England by 2035. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/hh4eb3sp/scientists-screen-looking-2025-871x581.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1db81ed8db87570"/>
                </item>
                <item>
                    <title>Are NHS patients keeping up with European neighbours on access to new medicines?</title>
<link>https://www.abpi.org.uk/media/blogs/2026/may/are-nhs-patients-keeping-up-with-european-neighbours-on-access-to-new-medicines/</link>                    <pubDate>Mon, 06 Jul 2026 10:52:09 GMT</pubDate>
                            <dc:creator><![CDATA[Sophie Caseby]]></dc:creator>
                            <category><![CDATA[Access]]></category>
                            <category><![CDATA[England]]></category>
                            <category><![CDATA[MHRA]]></category>
                            <category><![CDATA[NICE]]></category>
                            <category><![CDATA[Scotland]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2026/may/are-nhs-patients-keeping-up-with-european-neighbours-on-access-to-new-medicines/</guid>
                    <description><![CDATA[NHS patients in England rank 7th in Europe for access to newly approved medicines, according to the latest EFPIA W.A.I.T. Indicator report &#x2014; but significant gaps remain, particularly for cancer and rare disease treatments. With only 33% of medicines available on a fully unrestricted basis, and thousands of patients waiting for life-changing therapies, how does the UK compare to France, Germany, and other European neighbours? Read on for a full breakdown of the data and what it means for NHS patient access in 2026.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/1r2cza0i/public-2-871x581.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d9da41ce04f0e0"/>
                </item>
                <item>
                    <title>Understanding medicine shortages and how we&#x2019;re working to avoid them</title>
<link>https://www.abpi.org.uk/media/blogs/2026/march/understanding-medicine-shortages-and-how-we-re-working-to-avoid-them/</link>                    <pubDate>Mon, 06 Jul 2026 10:51:30 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2026/march/understanding-medicine-shortages-and-how-we-re-working-to-avoid-them/</guid>
                    <description><![CDATA[When it comes to medicines shortages, close working between the pharmaceutical industry, healthcare professionals, government and regulators is essential to ensure patients receive their medication on time and in full.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/q55n4rdk/patient-information-leaflet-2025-871x581.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1dc0d3a98c3b820"/>
                </item>
                <item>
                    <title>Innovation with integrity: Why NHS-industry partnerships matter, and how conflicts of interest are managed</title>
<link>https://www.abpi.org.uk/media/blogs/2026/march/innovation-with-integrity-why-nhs-industry-partnerships-matter-and-how-conflicts-of-interest-are-managed/</link>                    <pubDate>Mon, 06 Jul 2026 10:51:21 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[ABPI Code]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2026/march/innovation-with-integrity-why-nhs-industry-partnerships-matter-and-how-conflicts-of-interest-are-managed/</guid>
                    <description><![CDATA[Dr Amit Aggarwal discusses the importance of NHS-industry relationships, and the safeguards in place to ensure they always put patients and the NHS first. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/xziohiwe/review-871-581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ee51da00"/>
                </item>
                <item>
                    <title>Improving diversity in clinical trials is both an equity issue and a scientific necessity</title>
<link>https://www.abpi.org.uk/media/blogs/2026/march/improving-diversity-in-clinical-trials-is-both-an-equity-issue-and-a-scientific-necessity/</link>                    <pubDate>Mon, 06 Jul 2026 10:51:10 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Clinical research]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2026/march/improving-diversity-in-clinical-trials-is-both-an-equity-issue-and-a-scientific-necessity/</guid>
                    <description><![CDATA[Brian Duggan reflects on the need for more inclusive research]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/34lnw2yz/two-scientists-vial-871x581.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c978d897e40"/>
                </item>
                <item>
                    <title>Rare Disease Day: Prevention can be the most powerful treatment of all</title>
<link>https://www.abpi.org.uk/media/blogs/2026/february/rare-disease-day-prevention-can-be-the-most-powerful-treatment-of-all/</link>                    <pubDate>Mon, 06 Jul 2026 10:50:51 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Rare diseases]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2026/february/rare-disease-day-prevention-can-be-the-most-powerful-treatment-of-all/</guid>
                    <description><![CDATA[Dan O&#x2019;Connor reflects on the need for greater investment in prevention, as well as the need for equity, for this year&#x2019;s Rare Disease Day. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/jcgofh1n/women-scientist-microscope-871x581-webp75.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef19bde0"/>
                </item>
                <item>
                    <title>How regulation can help to unlock the potential of preventative medicines</title>
<link>https://www.abpi.org.uk/media/blogs/2024/july/how-regulation-can-help-to-unlock-the-potential-of-preventative-medicines/</link>                    <pubDate>Mon, 06 Jul 2026 10:47:38 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Regulatory]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2024/july/how-regulation-can-help-to-unlock-the-potential-of-preventative-medicines/</guid>
                    <description><![CDATA[A blog post on the potential of preventative medicines from Sarah Montagne, Bayer Senior Regulatory &amp; Policy Advisor (UKI), ABPI Regulatory Science Board Sponsored Group, Dr Dan O&#x2019;Connor, ABPI Director of Regulatory Policy and Early Access and Andy Collier, Regulatory Policy Manager]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/uashznt5/hands-agreement-580x405-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eed19150"/>
                </item>
                <item>
                    <title>Comparing new medicine availability across Europe</title>
<link>https://www.abpi.org.uk/media/blogs/2024/june/comparing-new-medicine-availability-across-europe/</link>                    <pubDate>Mon, 06 Jul 2026 10:47:28 GMT</pubDate>
                            <dc:creator><![CDATA[Orban Holdgate]]></dc:creator>
                            <category><![CDATA[Access]]></category>
                            <category><![CDATA[England]]></category>
                            <category><![CDATA[Health and Access to Medicines]]></category>
                            <category><![CDATA[Regulatory]]></category>
                            <category><![CDATA[Scotland]]></category>
                            <category><![CDATA[Value]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2024/june/comparing-new-medicine-availability-across-europe/</guid>
                    <description><![CDATA[Each year, the European Pharmaceutical Industry Association (EFPIA) publishes data comparing the availability of new medicines across 36 European countries, as well as the average time it takes to make these new medicines accessible to patients. This article explains what the data shows and what it means for the UK.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/pnafsqgg/doctor-patient-detail-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eee25a30"/>
                </item>
                <item>
                    <title>AMR: the silent undercurrent of modern medicine</title>
<link>https://www.abpi.org.uk/media/blogs/2024/may/amr-the-silent-undercurrent-of-modern-medicine/</link>                    <pubDate>Mon, 06 Jul 2026 10:47:20 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[AMR]]></category>
                            <category><![CDATA[Antibiotic resistance]]></category>
                            <category><![CDATA[Anti Microbial Resistance]]></category>
                            <category><![CDATA[Antibiotics]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2024/may/amr-the-silent-undercurrent-of-modern-medicine/</guid>
                    <description><![CDATA[A blog post from Dr Ron Daniels BEM, Executive Director, UK Sepsis Trust ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/wkjiyyde/msd-rd_web-460.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1daa83670908230"/>
                </item>
                <item>
                    <title>Familiarity and trust: Why it matters to industry reputation and what we can we do about it</title>
<link>https://www.abpi.org.uk/media/blogs/2024/march/familiarity-and-trust-why-it-matters-to-industry-reputation-and-what-we-can-we-do-about-it/</link>                    <pubDate>Mon, 06 Jul 2026 10:47:13 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Reputation]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2024/march/familiarity-and-trust-why-it-matters-to-industry-reputation-and-what-we-can-we-do-about-it/</guid>
                    <description><![CDATA[Jill Pearcy, the ABPI&#x27;s Director of reputation at the ABPI, talks about why familiarity and trust matters to the pharmaceutical industry. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/ra2leyup/scientists-lab-871x581.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c9812ef1ef0"/>
                </item>
                <item>
                    <title>June&#x2019;s story of sickle cell</title>
<link>https://www.abpi.org.uk/media/blogs/2024/february/june-s-story-of-sickle-cell/</link>                    <pubDate>Mon, 06 Jul 2026 10:47:03 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Rare diseases]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2024/february/june-s-story-of-sickle-cell/</guid>
                    <description><![CDATA[June has sickle cell, a genetic blood disorder that affects the red blood cells. She is one of the 1 in 17 people with a rare disease in the UK. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/mb2jntfx/june_rdd24_abpi.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1da6b30cf430890"/>
                </item>
                <item>
                    <title>Why we need the new Rare Therapies Launch Pad</title>
<link>https://www.abpi.org.uk/media/blogs/2024/february/why-we-need-the-new-rare-therapies-launch-pad/</link>                    <pubDate>Mon, 06 Jul 2026 10:46:57 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Rare diseases]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2024/february/why-we-need-the-new-rare-therapies-launch-pad/</guid>
                    <description><![CDATA[The ABPI&#x2019;s Director of Regulatory and Early Access Policy Dr Dan O&#x2019;Connor looks forward to an innovative initiative to improve access to personalised treatments for rare diseases.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/gpgpu4qr/dan-oconnor-871x581.jpg?rxy=0.513524741506647,0.09872213559786888&amp;width=240&amp;height=135&amp;quality=90&amp;v=1dac19a21f3c880"/>
                </item>
                <item>
                    <title>mRNA technology: navigating preclinical research for rare diseases</title>
<link>https://www.abpi.org.uk/media/blogs/2024/february/mrna-technology-navigating-preclinical-research-for-rare-diseases/</link>                    <pubDate>Mon, 06 Jul 2026 10:46:50 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Rare diseases]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2024/february/mrna-technology-navigating-preclinical-research-for-rare-diseases/</guid>
                    <description><![CDATA[Philip Cruz, Country Medical Director at Moderna UK talks about the potential of mRNA technology for rare diseases in a blog for Rare Disease Day 2024. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/u3lnwxcd/philip-cruz-moderna-871x571.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1da9c876ebbcb50"/>
                </item>
                <item>
                    <title>Leaving no one behind: The current measles outbreak demonstrates the importance of the NHS vaccination strategy</title>
<link>https://www.abpi.org.uk/media/blogs/2024/january/leaving-no-one-behind-the-current-measles-outbreak-demonstrates-the-importance-of-the-nhs-vaccination-strategy/</link>                    <pubDate>Mon, 06 Jul 2026 10:46:40 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Vaccines]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2024/january/leaving-no-one-behind-the-current-measles-outbreak-demonstrates-the-importance-of-the-nhs-vaccination-strategy/</guid>
                    <description><![CDATA[Vaccination is the best line of defence against disease outbreaks. The NHS vaccination strategy will make it easier for people to be protected in the future, says ABPI Medical Director Dr Amit Aggarwal.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/zlzjua4o/injection-arm-580x405-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef05e7c0"/>
                </item>
                <item>
                    <title>UK clinical trials performance improves but remains in intensive care</title>
<link>https://www.abpi.org.uk/media/news/2024/december/uk-clinical-trials-performance-improves-but-remains-in-intensive-care/</link>                    <pubDate>Fri, 03 Jul 2026 11:28:36 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/december/uk-clinical-trials-performance-improves-but-remains-in-intensive-care/</guid>
                    <description><![CDATA[A new report finds the UK&#x2019;s global rankings for industry clinical trial delivery are improving but further challenges must be overcome. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/at2lhehk/news-3-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d8b1a311387d50"/>
                </item>
                <item>
                    <title>Regulatory renewal needed for UK life sciences ambitions</title>
<link>https://www.abpi.org.uk/media/news/2024/december/regulatory-renewal-needed-for-uk-life-sciences-ambitions/</link>                    <pubDate>Fri, 03 Jul 2026 11:28:21 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Regulatory]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/december/regulatory-renewal-needed-for-uk-life-sciences-ambitions/</guid>
                    <description><![CDATA[A new report, &#x27;Enhancing the role of UK medicine regulation&#x27; sets out key recommendations to rebuild the UK&#x2019;s world-class reputation in regulatory science, medicines&#x2019; development and licensing.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/nrxnqdto/tablets-pills-capsules-blisters-871x571.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d8c44a900facc0"/>
                </item>
                <item>
                    <title>ABPI welcomes the Innovation Ecosystem Programme Review</title>
<link>https://www.abpi.org.uk/media/news/2024/november/abpi-welcomes-the-innovation-ecosystem-programme-review/</link>                    <pubDate>Fri, 03 Jul 2026 11:28:06 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Innovation]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/november/abpi-welcomes-the-innovation-ecosystem-programme-review/</guid>
                    <description><![CDATA[NHS England has published the Innovation Ecosystem Programme Review, recommending a package of measures to help the UK lead the way in health innovation.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/tmebfpef/technicians-operators-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52f001ace0"/>
                </item>
                <item>
                    <title>ABPI welcomes the appointment of new MHRA Chair</title>
<link>https://www.abpi.org.uk/media/news/2024/november/abpi-welcomes-the-appointment-of-new-mhra-chair/</link>                    <pubDate>Fri, 03 Jul 2026 11:27:54 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/november/abpi-welcomes-the-appointment-of-new-mhra-chair/</guid>
                    <description><![CDATA[Anthony Harnden has been appointed the new chair of the Medicine and Healthcare products Regulatory Agency. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/2jbpqqht/pharma-lab-871x581.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1db2c390bff4b80"/>
                </item>
                <item>
                    <title>The King&#x2019;s Fund calls on NHS leaders to help unlock power of industry partnerships</title>
<link>https://www.abpi.org.uk/media/news/2024/november/the-king-s-fund-calls-on-nhs-leaders-to-help-unlock-power-of-industry-partnerships/</link>                    <pubDate>Fri, 03 Jul 2026 11:27:42 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Partnership]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/november/the-king-s-fund-calls-on-nhs-leaders-to-help-unlock-power-of-industry-partnerships/</guid>
                    <description><![CDATA[The ABPI has welcomed a new report from The King&#x2019;s Fund which explores the positive impacts of NHS and industry partnerships.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/pglfbcdf/nurse-patient-hands-871x581.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef4c1880"/>
                </item>
                <item>
                    <title>UK missing opportunity to unlock medicines for severe conditions</title>
<link>https://www.abpi.org.uk/media/news/2024/november/uk-missing-opportunity-to-unlock-medicines-for-severe-conditions/</link>                    <pubDate>Fri, 03 Jul 2026 11:27:28 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/november/uk-missing-opportunity-to-unlock-medicines-for-severe-conditions/</guid>
                    <description><![CDATA[A new report shows the public wants more support for patients with severe conditions and is prepared to value associated medicines more highly than the current levels used by NICE.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/pgwagn03/doctor-patient-bedside-871x581-web75.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eefc4ad0"/>
                </item>
                <item>
                    <title>ABPI response to Sudlow review on the use of health data</title>
<link>https://www.abpi.org.uk/media/news/2024/october/abpi-response-to-sudlow-review-on-the-use-of-health-data/</link>                    <pubDate>Fri, 03 Jul 2026 11:27:08 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Health data]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/october/abpi-response-to-sudlow-review-on-the-use-of-health-data/</guid>
                    <description><![CDATA[An independent review has revealed that complexities and inefficiencies within the UK&#x2019;s health data infrastructure are hindering the effective use of health data resources critical for improving people&#x2019;s health]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/jgrn2v23/data-woman-explain-871x581.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef712cb0"/>
                </item>
                <item>
                    <title>ABPI welcomes the Chancellor&#x2019;s backing of life sciences in the Budget</title>
<link>https://www.abpi.org.uk/media/news/2024/october/abpi-welcomes-the-chancellor-s-backing-of-life-sciences-in-the-budget/</link>                    <pubDate>Fri, 03 Jul 2026 11:26:57 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Budget]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/october/abpi-welcomes-the-chancellor-s-backing-of-life-sciences-in-the-budget/</guid>
                    <description><![CDATA[The Association of the British Pharmaceutical Industry (ABPI) welcomes Chancellor Rachel Reeves&#x2019; measures to improve UK life sciences competitiveness.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/x1alyovv/quality-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eff2dfd0"/>
                </item>
                <item>
                    <title>Fixing NHS needs greater investment in medicines, says ABPI</title>
<link>https://www.abpi.org.uk/media/news/2024/october/fixing-nhs-needs-greater-investment-in-medicines-says-abpi/</link>                    <pubDate>Fri, 03 Jul 2026 11:26:39 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[#ValuingVaccines]]></category>
                            <category><![CDATA[NHS]]></category>
                            <category><![CDATA[NHS Commercial Framework for New Medicines]]></category>
                            <category><![CDATA[Pricing]]></category>
                            <category><![CDATA[Voluntary Scheme]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/october/fixing-nhs-needs-greater-investment-in-medicines-says-abpi/</guid>
                    <description><![CDATA[As the Health Secretary kicks off a national conversation to shape the government&#x2019;s 10 plan to overhaul the NHS, the ABPI points to the vital role medicines and vaccines can play.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/jzhf4iso/clinical-medicine-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52f0559940"/>
                </item>
                <item>
                    <title>MPs and peers urge Chancellor to support the life sciences in Budget</title>
<link>https://www.abpi.org.uk/media/news/2024/october/mps-and-peers-urge-chancellor-to-support-the-life-sciences-in-budget/</link>                    <pubDate>Fri, 03 Jul 2026 11:26:28 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/october/mps-and-peers-urge-chancellor-to-support-the-life-sciences-in-budget/</guid>
                    <description><![CDATA[A new group of MPs and peers have written to the Chancellor urging her to protect and promote the UK&#x2019;s world-leading life sciences sector in the government&#x27;s first Budget.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/l5lb4t5p/mps-871x581.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d9da41cdd52e50"/>
                </item>
                <item>
                    <title>Partnerships build trust between industry and healthcare professionals</title>
<link>https://www.abpi.org.uk/media/news/2024/october/partnerships-build-trust-between-industry-and-healthcare-professionals/</link>                    <pubDate>Fri, 03 Jul 2026 11:26:15 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/october/partnerships-build-trust-between-industry-and-healthcare-professionals/</guid>
                    <description><![CDATA[New polling data shows that healthcare professionals&#x27; trust in the pharmaceutical industry increases the more familiar they are with it.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/5ugnkl24/medical-information-871x581.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52efcedd10"/>
                </item>
                <item>
                    <title>Labour budget can unlock UK life science opportunities</title>
<link>https://www.abpi.org.uk/media/news/2024/october/labour-budget-can-unlock-uk-life-science-opportunities/</link>                    <pubDate>Fri, 03 Jul 2026 11:26:04 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Budget]]></category>
                            <category><![CDATA[Economy and Industry]]></category>
                            <category><![CDATA[Politics]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/october/labour-budget-can-unlock-uk-life-science-opportunities/</guid>
                    <description><![CDATA[Ahead of the first Labour budget for 14 years, the Association of the British Pharmaceutical Industry (ABPI) has outlined the key measures needed to improve UK life science competitiveness, boost UK R&amp;D, and fully realise the benefits of innovative medicines and vaccines for NHS patients.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/qyofdl1v/computational-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52f044d060"/>
                </item>
                <item>
                    <title>Emerging research points to NHS and industry being a successful partnership for patients</title>
<link>https://www.abpi.org.uk/media/news/2024/october/emerging-research-points-to-nhs-and-industry-being-a-successful-partnership-for-patients/</link>                    <pubDate>Fri, 03 Jul 2026 11:25:50 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Partnership]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/october/emerging-research-points-to-nhs-and-industry-being-a-successful-partnership-for-patients/</guid>
                    <description><![CDATA[Early evidence links NHS-industry partnerships with improved prescribing practices and better health outcomes for patients.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/yheezl41/doctor-consult-bed-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef31b2b0"/>
                </item>
                <item>
                    <title>ABPI response to United Nations General Assembly political declaration on&#xA0;antimicrobial resistance</title>
<link>https://www.abpi.org.uk/media/news/2024/september/abpi-response-to-united-nations-general-assembly-political-declaration-on-antimicrobial-resistance/</link>                    <pubDate>Fri, 03 Jul 2026 11:25:19 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/september/abpi-response-to-united-nations-general-assembly-political-declaration-on-antimicrobial-resistance/</guid>
                    <description><![CDATA[World leaders came together for the High-level Meeting on antimicrobial resistance (AMR) during the 79th session of the United Nations General Assembly. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/wkjiyyde/msd-rd_web-460.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1daa83670908230"/>
                </item>
                <item>
                    <title>Government must free NICE to unlock access to medicines for severe conditions</title>
<link>https://www.abpi.org.uk/media/news/2024/september/government-must-free-nice-to-unlock-access-to-medicines-for-severe-conditions/</link>                    <pubDate>Fri, 03 Jul 2026 11:25:08 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Voluntary Scheme]]></category>
                            <category><![CDATA[Voluntary Scheme News]]></category>
                            <category><![CDATA[NICE]]></category>
                            <category><![CDATA[NICE Methods Review]]></category>
                            <category><![CDATA[Health and Access to Medicines]]></category>
                            <category><![CDATA[NHS Commercial Framework for New Medicines]]></category>
                            <category><![CDATA[Severity modifier]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/september/government-must-free-nice-to-unlock-access-to-medicines-for-severe-conditions/</guid>
                    <description><![CDATA[The board of NICE has today decided not to change how it values medicines for those with severe health conditions, meaning some patients will continue to miss out on treatments that would have been approved under a previous system.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/awfgfsmy/doctor-lung-580x405-web60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ee9aa2d0"/>
                </item>
                <item>
                    <title>ABPI welcomes Chancellor&#x2019;s speech at Labour party conference</title>
<link>https://www.abpi.org.uk/media/news/2024/september/abpi-welcomes-chancellor-s-speech-at-labour-party-conference/</link>                    <pubDate>Fri, 03 Jul 2026 11:24:55 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[ABPI Manifesto]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/september/abpi-welcomes-chancellor-s-speech-at-labour-party-conference/</guid>
                    <description><![CDATA[Chancellor Rachel Reeves addressed the Labour Party Conference, setting out Labour&#x2019;s plans for economic stability and growth. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/hmibbi0s/biochemical-research-580x405-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eea1a7b0"/>
                </item>
                <item>
                    <title>2024 ABPI Code of Practice launched, with a new constitution and procedure for the PMCPA</title>
<link>https://www.abpi.org.uk/media/news/2024/september/2024-abpi-code-of-practice-launched-with-a-new-constitution-and-procedure-for-the-pmcpa/</link>                    <pubDate>Fri, 03 Jul 2026 11:24:44 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/september/2024-abpi-code-of-practice-launched-with-a-new-constitution-and-procedure-for-the-pmcpa/</guid>
                    <description><![CDATA[The ABPI and the PMCPA have published an updated Code of Practice for the pharmaceutical industry.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/axgnabjp/code_image_aggregation.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1db81f95fcf69f0"/>
                </item>
                <item>
                    <title>PM says life sciences is a key partner to fixing the NHS</title>
<link>https://www.abpi.org.uk/media/news/2024/september/pm-says-life-sciences-is-a-key-partner-to-fixing-the-nhs/</link>                    <pubDate>Fri, 03 Jul 2026 11:24:31 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[NHS]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/september/pm-says-life-sciences-is-a-key-partner-to-fixing-the-nhs/</guid>
                    <description><![CDATA[The Prime Minister has committed to putting the full weight of the British government behind life sciences as part of his plan to fix the NHS.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/dkmh2k31/microscope-laptop-580x405-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eec7cd50"/>
                </item>
                <item>
                    <title>ABPI response to the Darzi Review: innovation must be at the heart of improvement</title>
<link>https://www.abpi.org.uk/media/news/2024/september/abpi-response-to-the-darzi-review-innovation-must-be-at-the-heart-of-improvement/</link>                    <pubDate>Fri, 03 Jul 2026 11:24:13 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[NHS]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/september/abpi-response-to-the-darzi-review-innovation-must-be-at-the-heart-of-improvement/</guid>
                    <description><![CDATA[The innovative pharmaceutical industry is ready to be an active partner in helping to fix the broken NHS. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/pnafsqgg/doctor-patient-detail-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eee25a30"/>
                </item>
                <item>
                    <title>Industry calls on government to boost investment in commercial clinical trial capacity to drive &#xA3;3 billion extra economic growth, 26,000 new jobs</title>
<link>https://www.abpi.org.uk/media/news/2024/september/industry-calls-on-government-to-boost-investment-in-commercial-clinical-trial-capacity-to-drive-3-billion-extra-economic-growth-26-000-new-jobs/</link>                    <pubDate>Fri, 03 Jul 2026 11:23:58 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/september/industry-calls-on-government-to-boost-investment-in-commercial-clinical-trial-capacity-to-drive-3-billion-extra-economic-growth-26-000-new-jobs/</guid>
                    <description><![CDATA[New data shows that industry clinical trials contributed &#xA3;7.4 billion GVA to the UK economy in 2022]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/gv3pzmvi/eyes-microscope-close-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef364690"/>
                </item>
                <item>
                    <title>Russell Abberley, Amgen UK &amp; Ireland, steps up as Acting ABPI President</title>
<link>https://www.abpi.org.uk/media/news/2024/september/russell-abberley-amgen-uk-ireland-steps-up-as-acting-abpi-president/</link>                    <pubDate>Fri, 03 Jul 2026 11:23:47 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/september/russell-abberley-amgen-uk-ireland-steps-up-as-acting-abpi-president/</guid>
                    <description><![CDATA[Former ABPI Vice-President takes up President role on an interim basis ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/a4aovsx3/russell_abberley_actingabpi_president.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1db81eee3a3e450"/>
                </item>
                <item>
                    <title>UK secures &#xA3;400 million investment to boost clinical trials</title>
<link>https://www.abpi.org.uk/media/news/2024/august/uk-secures-400-million-investment-to-boost-clinical-trials/</link>                    <pubDate>Fri, 03 Jul 2026 11:23:33 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Clinical research]]></category>
                            <category><![CDATA[Economy and Industry]]></category>
                            <category><![CDATA[Manufacturing]]></category>
                            <category><![CDATA[NICE]]></category>
                            <category><![CDATA[Research and Development]]></category>
                            <category><![CDATA[Science and innovation]]></category>
                            <category><![CDATA[Scotland]]></category>
                            <category><![CDATA[Voluntary Scheme]]></category>
                            <category><![CDATA[Voluntary Scheme News]]></category>
                            <category><![CDATA[ABPI Cymru Wales Weekly Digest]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/august/uk-secures-400-million-investment-to-boost-clinical-trials/</guid>
                    <description><![CDATA[World-first public-private collaboration launched to kickstart economic growth and build an NHS fit for the future.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/5tyjzxue/female-pipette-bench-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef73c4c0"/>
                </item>
                <item>
                    <title>A-Level students urged to consider pharmaceutical careers</title>
<link>https://www.abpi.org.uk/media/news/2024/august/a-level-students-urged-to-consider-pharmaceutical-careers/</link>                    <pubDate>Fri, 03 Jul 2026 11:23:22 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/august/a-level-students-urged-to-consider-pharmaceutical-careers/</guid>
                    <description><![CDATA[]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/zvpilozj/adobestock_536708880.jpeg?width=240&amp;height=135&amp;quality=90&amp;v=1daef1669a41190"/>
                </item>
                <item>
                    <title>ABPI response to the government&#x27;s commitment to boost research by improving access to NHS data</title>
<link>https://www.abpi.org.uk/media/news/2024/july/abpi-response-to-the-governments-commitment-to-boost-research-by-improving-access-to-nhs-data/</link>                    <pubDate>Fri, 03 Jul 2026 11:22:57 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/july/abpi-response-to-the-governments-commitment-to-boost-research-by-improving-access-to-nhs-data/</guid>
                    <description><![CDATA[Government Ministers want to boost research by making it easier for companies to access NHS data.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/5l2beqty/event-930x930-doctor-older-patient-webp75.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ee8ee300"/>
                </item>
                <item>
                    <title>ABPI respond to the government&#x27;s Skills England announcement</title>
<link>https://www.abpi.org.uk/media/news/2024/july/abpi-respond-to-the-governments-skills-england-announcement/</link>                    <pubDate>Fri, 03 Jul 2026 11:22:46 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/july/abpi-respond-to-the-governments-skills-england-announcement/</guid>
                    <description><![CDATA[The Prime Minister and Education Secretary have announced the launch of Skills England to bring together the fractured skills landscape and create a shared national ambition to boost the nation&#x2019;s skills.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/ra2leyup/scientists-lab-871x581.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c9812ef1ef0"/>
                </item>
                <item>
                    <title>ABPI welcomes RSV national vaccination programme</title>
<link>https://www.abpi.org.uk/media/news/2024/july/abpi-welcomes-rsv-national-vaccination-programme/</link>                    <pubDate>Fri, 03 Jul 2026 11:22:37 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Vaccines]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/july/abpi-welcomes-rsv-national-vaccination-programme/</guid>
                    <description><![CDATA[The government has announced a new national respiratory syncytial virus (RSV) vaccine programme, which will protect infants and older people. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/r5gfhzmm/doctor-vaccine-arm-580x405-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eeb38200"/>
                </item>
                <item>
                    <title>New research shows why Gen-Z is choosing to work in pharma</title>
<link>https://www.abpi.org.uk/media/news/2024/july/new-research-shows-why-gen-z-is-choosing-to-work-in-pharma/</link>                    <pubDate>Fri, 03 Jul 2026 11:22:25 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/july/new-research-shows-why-gen-z-is-choosing-to-work-in-pharma/</guid>
                    <description><![CDATA[Younger workers are increasingly choosing careers in pharmaceuticals over other leading industries like technology or finance due to perceptions of better work life balance and social purpose in the sector.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/qzjezulo/adobestock_462197775.jpeg?rxy=0.4968108190187081,0.32150126834211973&amp;width=240&amp;height=135&amp;quality=90&amp;v=1db68c283dd63b0"/>
                </item>
                <item>
                    <title>Life sciences sector a vital partner for Labour&#x2019;s plans</title>
<link>https://www.abpi.org.uk/media/news/2024/july/life-sciences-sector-a-vital-partner-for-labour-s-plans/</link>                    <pubDate>Fri, 03 Jul 2026 11:21:49 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[ABPI Manifesto]]></category>
                            <category><![CDATA[ABPI Manifesto (1)]]></category>
                            <category><![CDATA[Economy and Industry]]></category>
                            <category><![CDATA[Health and Access to Medicines]]></category>
                            <category><![CDATA[Politics]]></category>
                            <category><![CDATA[Vaccines]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/july/life-sciences-sector-a-vital-partner-for-labour-s-plans/</guid>
                    <description><![CDATA[Richard Torbett offers his congratulations to Keir Starmer and the Labour Party on winning the 2024 General Election.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/hh4eb3sp/scientists-screen-looking-2025-871x581.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1db81ed8db87570"/>
                </item>
                <item>
                    <title>ABPI cheers new gene therapy for IMF and innovative payment first</title>
<link>https://www.abpi.org.uk/media/news/2024/june/abpi-cheers-new-gene-therapy-for-imf-and-innovative-payment-first/</link>                    <pubDate>Fri, 03 Jul 2026 11:21:25 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Access]]></category>
                            <category><![CDATA[Health and Access to Medicines]]></category>
                            <category><![CDATA[NHS Commercial Framework for New Medicines]]></category>
                            <category><![CDATA[NICE]]></category>
                            <category><![CDATA[Pricing]]></category>
                            <category><![CDATA[Value]]></category>
                            <category><![CDATA[Innovative Medicines Fund (IMF)]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/june/abpi-cheers-new-gene-therapy-for-imf-and-innovative-payment-first/</guid>
                    <description><![CDATA[The ABPI has welcomed the first gene therapy to be granted managed access through the Innovative Medicines Fund (IMF), alongside an agreement for an innovative payment model.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/m2zhbrml/fingers-vial-blue-871x581.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef6c23a0"/>
                </item>
                <item>
                    <title>ABPI response to the Labour 2024 election manifesto</title>
<link>https://www.abpi.org.uk/media/news/2024/june/abpi-response-to-the-labour-2024-election-manifesto/</link>                    <pubDate>Fri, 03 Jul 2026 11:21:09 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Politics]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/june/abpi-response-to-the-labour-2024-election-manifesto/</guid>
                    <description><![CDATA[The Labour Party published its Manifesto for the 2024 general election, which includes plans for policies to support the UK&#x2019;s life sciences sector, alongside other growth sectors. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/hoxk0in2/interview-871x571.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52f0d3c9f0"/>
                </item>
                <item>
                    <title>ABPI response to the Conservative 2024 election manifesto</title>
<link>https://www.abpi.org.uk/media/news/2024/june/abpi-response-to-the-conservative-2024-election-manifesto/</link>                    <pubDate>Fri, 03 Jul 2026 11:20:58 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Politics]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/june/abpi-response-to-the-conservative-2024-election-manifesto/</guid>
                    <description><![CDATA[The Conservative and Unionist Party has published its Manifesto for the 2024 general election, which includes plans for policies to support the UK&#x2019;s life sciences sector. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/k33aj2pn/two-men-glass-window-871x581.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1db2c390c52c2b0"/>
                </item>
                <item>
                    <title>Election must deliver a win for UK life science, say ABPI</title>
<link>https://www.abpi.org.uk/media/news/2024/june/election-must-deliver-a-win-for-uk-life-science-say-abpi/</link>                    <pubDate>Fri, 03 Jul 2026 11:20:47 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Politics]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/june/election-must-deliver-a-win-for-uk-life-science-say-abpi/</guid>
                    <description><![CDATA[The ABPI has issued a challenge to all political parties to set out in detail how they will unlock the industry&#x2019;s potential to drive UK heath and economic growth.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/l5lb4t5p/mps-871x581.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d9da41cdd52e50"/>
                </item>
                <item>
                    <title>Russell Abberley, Amgen UK &amp; Ireland, named as new ABPI Vice President</title>
<link>https://www.abpi.org.uk/media/news/2024/may/russell-abberley-amgen-uk-ireland-named-as-new-abpi-vice-president/</link>                    <pubDate>Fri, 03 Jul 2026 11:20:34 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/may/russell-abberley-amgen-uk-ireland-named-as-new-abpi-vice-president/</guid>
                    <description><![CDATA[The Association of the British Pharmaceutical Industry (ABPI) has appointed Russell Abberley as Vice-President of the ABPI.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/ii3hmig4/russell-abberley-871x571.jpg?rxy=0.6185482532218503,0.042853660146984884&amp;width=240&amp;height=135&amp;quality=90&amp;v=1dac19a6ea03b50"/>
                </item>
                <item>
                    <title>ABPI response to Labour pledges</title>
<link>https://www.abpi.org.uk/media/news/2024/may/abpi-response-to-labour-pledges/</link>                    <pubDate>Fri, 03 Jul 2026 11:20:20 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Partnership]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/may/abpi-response-to-labour-pledges/</guid>
                    <description><![CDATA[This morning Sir Keir Starmer made a speech setting out his pledges if Labour wins the next election, including on health and the economy.  ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/klidc23t/women-eye-chart-871x581.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef27eeb0"/>
                </item>
                <item>
                    <title>ABPI respond to proposals to change the Statutory Scheme</title>
<link>https://www.abpi.org.uk/media/news/2024/may/abpi-respond-to-proposals-to-change-the-statutory-scheme/</link>                    <pubDate>Fri, 03 Jul 2026 11:20:10 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Statutory Scheme]]></category>
                            <category><![CDATA[Voluntary Scheme]]></category>
                            <category><![CDATA[Voluntary Scheme News]]></category>
                            <category><![CDATA[Pricing]]></category>
                            <category><![CDATA[Access]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/may/abpi-respond-to-proposals-to-change-the-statutory-scheme/</guid>
                    <description><![CDATA[The Association of the British Pharmaceutical Industry (ABPI) has published an executive summary of its consultation response to the government&#x27;s proposed changes to the Statutory Scheme for branded medicines.&#xA;]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/xeom40nk/event-930x930-hands-planning-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ee7a97b0"/>
                </item>
                <item>
                    <title>Embracing innovation can improve care and ease NHS pressures</title>
<link>https://www.abpi.org.uk/media/news/2024/april/embracing-innovation-can-improve-care-and-ease-nhs-pressures/</link>                    <pubDate>Fri, 03 Jul 2026 11:19:58 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Partnership]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/april/embracing-innovation-can-improve-care-and-ease-nhs-pressures/</guid>
                    <description><![CDATA[Creating a culture of innovation can improve care and tackle some of the pressures faced by healthcare professionals, according to a new joint report from NHS leaders, charity CEOs and the pharmaceutical industry.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/awfgfsmy/doctor-lung-580x405-web60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ee9aa2d0"/>
                </item>
                <item>
                    <title>GSK&#x2019;s Bill Dawson appointed head of UK medicines manufacturing alliance</title>
<link>https://www.abpi.org.uk/media/news/2024/march/gsk-s-bill-dawson-appointed-head-of-uk-medicines-manufacturing-alliance/</link>                    <pubDate>Fri, 03 Jul 2026 11:19:44 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Manufacturing]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/march/gsk-s-bill-dawson-appointed-head-of-uk-medicines-manufacturing-alliance/</guid>
                    <description><![CDATA[Bill Dawson, Head of Biologics and Devices Manufacturing at GSK, has been appointed the new Chair of the MMIP, a body representing the voice of medicines manufacturing in the UK.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/nynmdbm5/bill_dawson_x_landscape.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1db81f80d134200"/>
                </item>
                <item>
                    <title>WTO Ministerial Conference in Abu Dhabi an opportunity to strengthen trade and health agenda</title>
<link>https://www.abpi.org.uk/media/news/2024/february/wto-ministerial-conference-in-abu-dhabi-an-opportunity-to-strengthen-trade-and-health-agenda/</link>                    <pubDate>Fri, 03 Jul 2026 11:19:11 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[International]]></category>
                            <category><![CDATA[Intellectual Property]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/february/wto-ministerial-conference-in-abu-dhabi-an-opportunity-to-strengthen-trade-and-health-agenda/</guid>
                    <description><![CDATA[Joint industry associations statement on the meeting of global trade ministers at the World Trade Organization&#x2019;s 13th Ministerial Conference in Abu Dhabi (MC13).]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/r5gpft2r/wto-hq.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1da6640f2b0e3f0"/>
                </item>
                <item>
                    <title>UK life science industry sets out priorities for the Budget</title>
<link>https://www.abpi.org.uk/media/news/2024/february/uk-life-science-industry-sets-out-priorities-for-the-budget/</link>                    <pubDate>Fri, 03 Jul 2026 11:19:00 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Budget]]></category>
                            <category><![CDATA[ABPI Manifesto]]></category>
                            <category><![CDATA[ABPI Manifesto (1)]]></category>
                            <category><![CDATA[Health and Access to Medicines]]></category>
                            <category><![CDATA[Life Sciences]]></category>
                            <category><![CDATA[Politics]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/february/uk-life-science-industry-sets-out-priorities-for-the-budget/</guid>
                    <description><![CDATA[The Association of the British Pharmaceutical Industry (ABPI) has set out the measures the UK&#x2019;s life sciences industry wants to see in Chancellor Jeremy Hunt&#x2019;s Budget on Wednesday, 6 March.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/0mgjexoi/mps-2-871x581.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d9da41cdf42800"/>
                </item>
                <item>
                    <title>How to make sure patients get faster and fairer access to new medicines</title>
<link>https://www.abpi.org.uk/media/news/2024/february/how-to-make-sure-patients-get-faster-and-fairer-access-to-new-medicines/</link>                    <pubDate>Fri, 03 Jul 2026 11:18:50 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/february/how-to-make-sure-patients-get-faster-and-fairer-access-to-new-medicines/</guid>
                    <description><![CDATA[In a new report, the ABPI&#x27;s Patient Advisory Council says that UK governments and NHS leaders need to start with a holistic view of patient need and improve fair access to the latest medical advances. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/00kl03qg/nursesl-871x581.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d9da41cdfdc4f0"/>
                </item>
                <item>
                    <title>ABPI statement on brain tumour research</title>
<link>https://www.abpi.org.uk/media/news/2024/february/abpi-statement-on-brain-tumour-research/</link>                    <pubDate>Fri, 03 Jul 2026 11:18:40 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Clinical research]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/february/abpi-statement-on-brain-tumour-research/</guid>
                    <description><![CDATA[The ABPI has responded to recent concerns from a charity that pharmaceutical companies are holding up brain tumour research. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/dkmh2k31/microscope-laptop-580x405-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eec7cd50"/>
                </item>
                <item>
                    <title>ABPI launches new prescribing support guide for healthcare professionals</title>
<link>https://www.abpi.org.uk/media/news/2024/february/abpi-launches-new-prescribing-support-guide-for-healthcare-professionals/</link>                    <pubDate>Fri, 03 Jul 2026 11:18:30 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[ABPI Code]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/february/abpi-launches-new-prescribing-support-guide-for-healthcare-professionals/</guid>
                    <description><![CDATA[A new guide to how the pharmaceutical industry can help healthcare professionals with complex prescribing decisions has been launched today by the ABPI. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/21zjbgkf/doctor-patient-talk-871x581.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d9af1fa473a6b0"/>
                </item>
                <item>
                    <title>ABPI Exam name change to widen professional appeal</title>
<link>https://www.abpi.org.uk/media/news/2024/february/abpi-exam-name-change-to-widen-professional-appeal/</link>                    <pubDate>Fri, 03 Jul 2026 11:18:19 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[ABPI Exam]]></category>
                            <category><![CDATA[ABPI Code]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/february/abpi-exam-name-change-to-widen-professional-appeal/</guid>
                    <description><![CDATA[A key pharmaceutical qualification has been given a new name to reflect its broader relevance to roles across the industry. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/h1jjhrca/pharmacists-medical-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52f084e6a0"/>
                </item>
                <item>
                    <title>The ABPI sets out its plan for investment, health and growth</title>
<link>https://www.abpi.org.uk/media/news/2024/february/the-abpi-sets-out-its-plan-for-investment-health-and-growth/</link>                    <pubDate>Fri, 03 Jul 2026 11:18:07 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[ABPI Manifesto]]></category>
                            <category><![CDATA[ABPI Manifesto (1)]]></category>
                            <category><![CDATA[ABPI news]]></category>
                            <category><![CDATA[Economy and Industry]]></category>
                            <category><![CDATA[Life Sciences]]></category>
                            <category><![CDATA[Manufacturing]]></category>
                            <category><![CDATA[Politics]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2024/february/the-abpi-sets-out-its-plan-for-investment-health-and-growth/</guid>
                    <description><![CDATA[The Association of the British Pharmaceutical Industry (ABPI) has published a manifesto outlining what a new government must do to make the UK the best place in the world to research, develop and use the medicines and vaccines of the future.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/fwnbt4ua/lab-working-871x581.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c98f516a0f0"/>
                </item>
                <item>
                    <title>Boost for transparency as highest ever rate of healthcare professionals named on Disclosure UK</title>
<link>https://www.abpi.org.uk/media/news/2023/june/boost-for-transparency-as-highest-ever-rate-of-healthcare-professionals-named-on-disclosure-uk/</link>                    <pubDate>Fri, 03 Jul 2026 11:10:56 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2023/june/boost-for-transparency-as-highest-ever-rate-of-healthcare-professionals-named-on-disclosure-uk/</guid>
                    <description><![CDATA[The proportion of named healthcare professionals (HCPs) in transparency data published on Disclosure UK has risen for the third year in a row.  ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/5l2beqty/event-930x930-doctor-older-patient-webp75.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ee8ee300"/>
                </item>
                <item>
                    <title>ABPI Regulatory Science symposium 2025</title>
<link>https://www.abpi.org.uk/media/blogs/2025/october/abpi-regulatory-science-symposium-2025/</link>                    <pubDate>Fri, 03 Jul 2026 10:35:12 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Regulatory]]></category>
                            <category><![CDATA[MHRA]]></category>
                            <category><![CDATA[NICE]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2025/october/abpi-regulatory-science-symposium-2025/</guid>
                    <description><![CDATA[The ABPI was pleased to host our second Regulatory Science Symposium which brought together leaders from across the life sciences ecosystem.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/ncdhwokx/events-audience-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ee69ced0"/>
                </item>
                <item>
                    <title>Public attitudes on the pharmaceutical industry: will increasing familiarity build confidence?</title>
<link>https://www.abpi.org.uk/media/blogs/2025/october/public-attitudes-on-the-pharmaceutical-industry-will-increasing-familiarity-build-confidence/</link>                    <pubDate>Fri, 03 Jul 2026 10:35:05 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Reputation]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2025/october/public-attitudes-on-the-pharmaceutical-industry-will-increasing-familiarity-build-confidence/</guid>
                    <description><![CDATA[Each year, the Association of the British Pharmaceutical Industry (ABPI) and Ipsos carry out quantitative and qualitative research with members of the public and healthcare professionals to understand how the pharmaceutical industry is viewed in the UK.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/g41ibnes/public-871x581.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d9da41ce1851d0"/>
                </item>
                <item>
                    <title>The UK must act to secure the future of UK life sciences and deliver for patients</title>
<link>https://www.abpi.org.uk/media/blogs/2025/september/the-uk-must-act-to-secure-the-future-of-uk-life-sciences-and-deliver-for-patients/</link>                    <pubDate>Fri, 03 Jul 2026 10:34:49 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Access]]></category>
                            <category><![CDATA[Economy and Industry]]></category>
                            <category><![CDATA[Health and Access to Medicines]]></category>
                            <category><![CDATA[Life Sciences]]></category>
                            <category><![CDATA[Medicines sales]]></category>
                            <category><![CDATA[NICE]]></category>
                            <category><![CDATA[Pricing]]></category>
                            <category><![CDATA[Politics]]></category>
                            <category><![CDATA[Research and Development]]></category>
                            <category><![CDATA[Science and innovation]]></category>
                            <category><![CDATA[Value]]></category>
                            <category><![CDATA[Voluntary Scheme]]></category>
                            <category><![CDATA[Voluntary Scheme News]]></category>
                            <category><![CDATA[VPAG]]></category>
                            <category><![CDATA[VPAG (1)]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2025/september/the-uk-must-act-to-secure-the-future-of-uk-life-sciences-and-deliver-for-patients/</guid>
                    <description><![CDATA[Richard Torbett, ABPI Chief Executive, sets out the stark choice facing the UK. Will uncertainty and short-term thinking erode the UK&#x27;s position as a life sciences centre, or can the UK take the decisive steps needed to restore confidence, attract investment, and ensure that patients in the UK benefit from the very best in modern medicine?]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/avgjryyt/mma-vaccine-871x581.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1da6e42002d0be0"/>
                </item>
                <item>
                    <title>UK medicines investment: the case for improving the UK commercial environment</title>
<link>https://www.abpi.org.uk/media/blogs/2025/september/uk-medicines-investment-the-case-for-improving-the-uk-commercial-environment/</link>                    <pubDate>Fri, 03 Jul 2026 10:34:34 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Voluntary Scheme]]></category>
                            <category><![CDATA[Commercial]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2025/september/uk-medicines-investment-the-case-for-improving-the-uk-commercial-environment/</guid>
                    <description><![CDATA[David Watson builds on The King&#x27;s Fund&#x27;s explainer on medicines pricing to make the case for policymakers to protect the UK&#x2019;s position in life sciences and ensure long-term patient access to new medicines. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/riwf5xcq/quality-control-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eff577e0"/>
                </item>
                <item>
                    <title>Disclosure UK 2024: new record for transparency, with nine in ten healthcare professionals named in database</title>
<link>https://www.abpi.org.uk/media/blogs/2025/june/disclosure-uk-2024-new-record-for-transparency-with-nine-in-ten-healthcare-professionals-named-in-database/</link>                    <pubDate>Fri, 03 Jul 2026 10:34:14 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Disclosure UK]]></category>
                            <category><![CDATA[Disclosure UK Publication]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2025/june/disclosure-uk-2024-new-record-for-transparency-with-nine-in-ten-healthcare-professionals-named-in-database/</guid>
                    <description><![CDATA[Dr Amit Aggarwal, ABPI Director of Medical Affairs, and Alex Fell, PMCPA Chief Executive, discuss the latest data published on Disclosure UK.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/3wnlijqi/plans3-871x581.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d9da41cda851f0"/>
                </item>
                <item>
                    <title>Why the pharmaceutical industry needs NHS data to develop new medicines</title>
<link>https://www.abpi.org.uk/media/blogs/2025/june/why-the-pharmaceutical-industry-needs-nhs-data-to-develop-new-medicines/</link>                    <pubDate>Fri, 03 Jul 2026 10:34:09 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Health data]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2025/june/why-the-pharmaceutical-industry-needs-nhs-data-to-develop-new-medicines/</guid>
                    <description><![CDATA[To help understand why NHS data is crucial for research, developing innovative, safe, and effective medicines, we have created a publicly accessible case study library.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/yheezl41/doctor-consult-bed-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef31b2b0"/>
                </item>
                <item>
                    <title>Trust, transparency and purpose &#x2013; managing reputation in a challenging environment</title>
<link>https://www.abpi.org.uk/media/blogs/2025/may/trust-transparency-and-purpose-managing-reputation-in-a-challenging-environment/</link>                    <pubDate>Fri, 03 Jul 2026 10:33:57 GMT</pubDate>
                            <category><![CDATA[Reputation]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2025/may/trust-transparency-and-purpose-managing-reputation-in-a-challenging-environment/</guid>
                    <description><![CDATA[Blog post by Seyda Atadan Memis, Takeda General Manager UK &amp; Ireland and ABPI Board Member]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/ziqjay0f/257_cm406077_abpi_industry-summit.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1dbc3e637375870"/>
                </item>
                <item>
                    <title>What does the latest data tell us about NHS patients&#x27; access to medicines?</title>
<link>https://www.abpi.org.uk/media/blogs/2025/may/what-does-the-latest-data-tell-us-about-nhs-patients-access-to-medicines/</link>                    <pubDate>Fri, 03 Jul 2026 10:33:51 GMT</pubDate>
                            <dc:creator><![CDATA[Victoria Jordan]]></dc:creator>
                            <category><![CDATA[Access]]></category>
                            <category><![CDATA[Devolved Nations - Scotland]]></category>
                            <category><![CDATA[England]]></category>
                            <category><![CDATA[Health and Access to Medicines]]></category>
                            <category><![CDATA[NICE]]></category>
                            <category><![CDATA[Supply]]></category>
                            <category><![CDATA[Value]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2025/may/what-does-the-latest-data-tell-us-about-nhs-patients-access-to-medicines/</guid>
                    <description><![CDATA[Understanding how well the system performs in meeting the NHS&#x2019;s ambition for patients to have rapid access to effective new medicines is not easy. There are several sources of data, and like any reporting of metrics, it isn&#x2019;t always immediately obvious what the data includes/excludes.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/yubpvozw/pharmacists-regulatory-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1dbbe87c06f1790"/>
                </item>
                <item>
                    <title>Celebrating our shared commitment to patient and public involvement in research</title>
<link>https://www.abpi.org.uk/media/blogs/2025/march/celebrating-our-shared-commitment-to-patient-and-public-involvement-in-research/</link>                    <pubDate>Fri, 03 Jul 2026 10:33:05 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2025/march/celebrating-our-shared-commitment-to-patient-and-public-involvement-in-research/</guid>
                    <description><![CDATA[Celebrating the three-year anniversary of our shared commitment to increasing the involvement of patients and members of the public in research. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/5l2beqty/event-930x930-doctor-older-patient-webp75.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ee8ee300"/>
                </item>
                <item>
                    <title>No room for complacency &#x2013; the UK must do more on access to rare disease medicines</title>
<link>https://www.abpi.org.uk/media/blogs/2025/february/no-room-for-complacency-the-uk-must-do-more-on-access-to-rare-disease-medicines/</link>                    <pubDate>Fri, 03 Jul 2026 10:32:51 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2025/february/no-room-for-complacency-the-uk-must-do-more-on-access-to-rare-disease-medicines/</guid>
                    <description><![CDATA[Blog post by Richard Torbett, ABPI Chief Executive for Rare Disease Day 2025 ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/1f0lkzvd/sterile-capsules-580x405-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eecef940"/>
                </item>
                <item>
                    <title>Speedy Anna is now award-winning</title>
<link>https://www.abpi.org.uk/media/blogs/2025/february/speedy-anna-is-now-award-winning/</link>                    <pubDate>Fri, 03 Jul 2026 10:32:43 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Rare diseases]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2025/february/speedy-anna-is-now-award-winning/</guid>
                    <description><![CDATA[In 2020, we spoke to Anna Turner and her Mum Jenna from Waringstown, Northern Ireland, to get their perspective on living with hypophosphatasia (HPP). In 2024 we caught up with Jenna again to see how Anna, now 12, is doing.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/3rqfugom/anna-turner-2025-871x581.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1db82c4f3c35fb0"/>
                </item>
                <item>
                    <title>Achieving life sciences sector growth requires falling medicine payment rates</title>
<link>https://www.abpi.org.uk/media/blogs/2025/january/achieving-life-sciences-sector-growth-requires-falling-medicine-payment-rates/</link>                    <pubDate>Fri, 03 Jul 2026 10:32:20 GMT</pubDate>
                            <dc:creator><![CDATA[Dr Richard Torbett]]></dc:creator>
                            <category><![CDATA[Voluntary Scheme]]></category>
                            <category><![CDATA[Voluntary Scheme News]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2025/january/achieving-life-sciences-sector-growth-requires-falling-medicine-payment-rates/</guid>
                    <description><![CDATA[To tackle the economic stagnation of the last 15 years, the UK needs a strategy that aligns policy across government departments and avoids perverse incentives. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/2mzleyni/white-tablet-factory-871x581.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef7d61b0"/>
                </item>
                <item>
                    <title>Is investing in medicines harming the health of the UK population?</title>
<link>https://www.abpi.org.uk/media/blogs/2025/january/is-investing-in-medicines-harming-the-health-of-the-uk-population/</link>                    <pubDate>Fri, 03 Jul 2026 10:32:13 GMT</pubDate>
                            <dc:creator><![CDATA[Victoria Jordan]]></dc:creator>
                            <category><![CDATA[NHS Commercial Framework for New Medicines]]></category>
                            <category><![CDATA[NICE]]></category>
                            <category><![CDATA[Pricing]]></category>
                            <category><![CDATA[Value]]></category>
                            <category><![CDATA[Voluntary Scheme]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2025/january/is-investing-in-medicines-harming-the-health-of-the-uk-population/</guid>
                    <description><![CDATA[A recent study published in the Lancet has disputed the existing decision-making threshold used by NICE. The authors argue that allowing NHS patients access to new NICE-recommended medicines has, counterintuitively, harmed wider population health by displacing other more cost-effective areas of spending.&#xA;&#xA;In this blog, Victoria Jordan explains why the ABPI disagrees with this conclusion and examines some of the assumptions that underpin it.&#xA;]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/jihl0ma0/wheelchair-professional-871x581-webp75.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eeebf720"/>
                </item>
                <item>
                    <title>NHS England is taking welcome new steps to encourage clinical leaders to champion proven innovation in the NHS</title>
<link>https://www.abpi.org.uk/media/blogs/2024/december/nhs-england-is-taking-welcome-new-steps-to-encourage-clinical-leaders-to-champion-proven-innovation-in-the-nhs/</link>                    <pubDate>Fri, 03 Jul 2026 10:31:41 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2024/december/nhs-england-is-taking-welcome-new-steps-to-encourage-clinical-leaders-to-champion-proven-innovation-in-the-nhs/</guid>
                    <description><![CDATA[Dr Amit Aggarwal, Director of Medical Affairs at the Association of the British Pharmaceutical Industry (ABPI), welcomes the steps NHS England has taken to tackle inequalities in patient access to new medicines.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/dsdjc5k2/nurses-corridor-white-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef7858a0"/>
                </item>
                <item>
                    <title>NHS-industry partnerships can support the NHS to make the government&#x2019;s three big shifts</title>
<link>https://www.abpi.org.uk/media/blogs/2024/november/nhs-industry-partnerships-can-support-the-nhs-to-make-the-government-s-three-big-shifts/</link>                    <pubDate>Fri, 03 Jul 2026 10:31:32 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Partnership]]></category>
                            <category><![CDATA[NHS]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2024/november/nhs-industry-partnerships-can-support-the-nhs-to-make-the-government-s-three-big-shifts/</guid>
                    <description><![CDATA[the case for partnerships is stronger than ever, and sharing what works must be a crucial part of delivering the NHS 10-Year Plan. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/cm3l5qjx/pfizer-de-link.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d7dcb088651640"/>
                </item>
                <item>
                    <title>Celebrating UK progress in tackling the global threat of antimicrobial resistance (AMR)</title>
<link>https://www.abpi.org.uk/media/blogs/2024/november/celebrating-uk-progress-in-tackling-the-global-threat-of-antimicrobial-resistance-amr/</link>                    <pubDate>Fri, 03 Jul 2026 10:31:26 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[AMR]]></category>
                            <category><![CDATA[Anti Microbial Resistance]]></category>
                            <category><![CDATA[Antibiotic resistance]]></category>
                            <category><![CDATA[Antibiotics]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2024/november/celebrating-uk-progress-in-tackling-the-global-threat-of-antimicrobial-resistance-amr/</guid>
                    <description><![CDATA[World Antimicrobial Awareness Week blog by Amit Aggarwal, ABPI Executive Director, Medical Affairs and Strategic Partnerships. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/brcd3tef/pexels-katarzyna-modrzejewska-6203349-small.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1da0cab8fd590d0"/>
                </item>
                <item>
                    <title>World Teachers Day: Celebrating the heart of education</title>
<link>https://www.abpi.org.uk/media/blogs/2024/october/world-teachers-day-celebrating-the-heart-of-education/</link>                    <pubDate>Fri, 03 Jul 2026 10:31:18 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2024/october/world-teachers-day-celebrating-the-heart-of-education/</guid>
                    <description><![CDATA[Blog post by Andrew Croydon, ABPI Director, Education and Examination Policy]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/sh2bfzpz/teacher.png?width=240&amp;height=135&amp;quality=90&amp;v=1d7e2243b77dc90"/>
                </item>
                <item>
                    <title>The first six months of the 2024 Voluntary Scheme</title>
<link>https://www.abpi.org.uk/media/blogs/2024/october/the-first-six-months-of-the-2024-voluntary-scheme/</link>                    <pubDate>Fri, 03 Jul 2026 10:31:12 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2024/october/the-first-six-months-of-the-2024-voluntary-scheme/</guid>
                    <description><![CDATA[The newly agreed 2024 voluntary scheme for branded medicines pricing, access, and growth (VPAG) came into force at the beginning of January this year. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/jgrn2v23/data-woman-explain-871x581.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef712cb0"/>
                </item>
                <item>
                    <title>Getting ready for the Windsor Framework: ensuring continuity of UK medicines supply beyond 1 January 2025</title>
<link>https://www.abpi.org.uk/media/blogs/2024/october/getting-ready-for-the-windsor-framework-ensuring-continuity-of-uk-medicines-supply-beyond-1-january-2025/</link>                    <pubDate>Fri, 03 Jul 2026 10:31:07 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Regulatory]]></category>
                            <category><![CDATA[Supply]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2024/october/getting-ready-for-the-windsor-framework-ensuring-continuity-of-uk-medicines-supply-beyond-1-january-2025/</guid>
                    <description><![CDATA[The Windsor Framework, agreed between the UK and the EU in February 2023, is expected to be fully implemented on 1 January 2025. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/1vmpcc04/abpi-blister-pack-carbon-footprint-tool-930x930.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d81f3a6157ae10"/>
                </item>
                <item>
                    <title>Understanding medicines access: a look at the severity modifier and its impact</title>
<link>https://www.abpi.org.uk/media/blogs/2024/august/understanding-medicines-access-a-look-at-the-severity-modifier-and-its-impact/</link>                    <pubDate>Fri, 03 Jul 2026 10:30:58 GMT</pubDate>
                            <dc:creator><![CDATA[Orban Holdgate]]></dc:creator>
                            <category><![CDATA[NICE]]></category>
                            <category><![CDATA[NICE Methods Review]]></category>
                            <category><![CDATA[Severity modifier]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2024/august/understanding-medicines-access-a-look-at-the-severity-modifier-and-its-impact/</guid>
                    <description><![CDATA[In recent years, NICE has introduced a new way of deciding how much value to assign to some treatments, which is called the severity modifier. But what exactly is the severity modifier, and why is it important?]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/pgwagn03/doctor-patient-bedside-871x581-web75.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eefc4ad0"/>
                </item>
                <item>
                    <title>Latest Disclosure UK data: higher R&amp;D spend, greater transparency and more partnership with the NHS</title>
<link>https://www.abpi.org.uk/media/blogs/2024/july/latest-disclosure-uk-data-higher-rd-spend-greater-transparency-and-more-partnership-with-the-nhs/</link>                    <pubDate>Fri, 03 Jul 2026 10:30:50 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Disclosure UK]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2024/july/latest-disclosure-uk-data-higher-rd-spend-greater-transparency-and-more-partnership-with-the-nhs/</guid>
                    <description><![CDATA[The 2023 Disclosure UK data continues to show positive trends, says the ABPI&#x2019;s Medical Director Dr Amit Aggarwal. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/00kl03qg/nursesl-871x581.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d9da41cdfdc4f0"/>
                </item>
                <item>
                    <title>UK must do more on access to rare disease medicines, says ABPI</title>
<link>https://www.abpi.org.uk/media/news/2025/february/uk-must-do-more-on-access-to-rare-disease-medicines-says-abpi/</link>                    <pubDate>Wed, 01 Jul 2026 12:34:15 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/february/uk-must-do-more-on-access-to-rare-disease-medicines-says-abpi/</guid>
                    <description><![CDATA[The latest England action plan on rare diseases (published 28 February 2025) does not do enough to ensure NHS patients get access to potentially life-changing new medicines, according to the Association of the British Pharmaceutical Industry (ABPI).]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/j55bfqs1/working-nhs-871x581.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1db2c390c438070"/>
                </item>
                <item>
                    <title>UK tumbles down global rankings for pharma investment and research</title>
<link>https://www.abpi.org.uk/media/news/2025/september/uk-tumbles-down-global-rankings-for-pharma-investment-and-research/</link>                    <pubDate>Wed, 01 Jul 2026 12:29:42 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Access]]></category>
                            <category><![CDATA[Budget]]></category>
                            <category><![CDATA[Clinical research]]></category>
                            <category><![CDATA[Commercial]]></category>
                            <category><![CDATA[Economy and Industry]]></category>
                            <category><![CDATA[G7]]></category>
                            <category><![CDATA[Health and Access to Medicines]]></category>
                            <category><![CDATA[Health data]]></category>
                            <category><![CDATA[Intellectual Property]]></category>
                            <category><![CDATA[Innovation]]></category>
                            <category><![CDATA[International]]></category>
                            <category><![CDATA[International research]]></category>
                            <category><![CDATA[Life Sciences]]></category>
                            <category><![CDATA[Manufacturing]]></category>
                            <category><![CDATA[Medicines sales]]></category>
                            <category><![CDATA[Politics]]></category>
                            <category><![CDATA[Pricing]]></category>
                            <category><![CDATA[Reputation]]></category>
                            <category><![CDATA[Research and Development]]></category>
                            <category><![CDATA[Rest of the World]]></category>
                            <category><![CDATA[Science and innovation]]></category>
                            <category><![CDATA[Statistics]]></category>
                            <category><![CDATA[Trade]]></category>
                            <category><![CDATA[UK-EU]]></category>
                            <category><![CDATA[Value]]></category>
                            <category><![CDATA[Voluntary Scheme]]></category>
                            <category><![CDATA[VPAG]]></category>
                            <category><![CDATA[VPAG (1)]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/september/uk-tumbles-down-global-rankings-for-pharma-investment-and-research/</guid>
                    <description><![CDATA[A new Pharmaceutical Competitiveness Framework reveals that the UK is losing the race for investment in R&amp;D, clinical trial delivery, and foreign direct investment, due to increasing drags on competitiveness.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/3calxvpd/g7-flags-580x405-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eeb99c80"/>
                </item>
                <item>
                    <title>The UK risks undervaluing life sciences manufacturing investment</title>
<link>https://www.abpi.org.uk/media/news/2025/september/the-uk-risks-undervaluing-life-sciences-manufacturing-investment/</link>                    <pubDate>Wed, 01 Jul 2026 12:29:42 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Research and Development]]></category>
                            <category><![CDATA[Manufacturing]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/september/the-uk-risks-undervaluing-life-sciences-manufacturing-investment/</guid>
                    <description><![CDATA[The official methods used by the UK government to assess the value of innovative life sciences manufacturing may lead the UK to miss out on strategic investments and the jobs and productivity growth they can bring to all regions across the UK]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/rcbecr0f/biotherapeutics-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52f042d490"/>
                </item>
                <item>
                    <title>Companies granted extension to VPAG 2026 decision deadline</title>
<link>https://www.abpi.org.uk/media/news/2025/september/companies-granted-extension-to-vpag-2026-decision-deadline/</link>                    <pubDate>Wed, 01 Jul 2026 12:29:42 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[VPAG]]></category>
                            <category><![CDATA[VPAG (1)]]></category>
                            <category><![CDATA[Voluntary Scheme]]></category>
                            <category><![CDATA[Voluntary Scheme News]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/september/companies-granted-extension-to-vpag-2026-decision-deadline/</guid>
                    <description><![CDATA[The ABPI and the government have agreed to a four-week extension to the deadline by which companies must give notice if they intend to leave the 2024 voluntary scheme for branded medicines pricing, access and growth (VPAG). The revised deadline for submitting notice to leave the VPAG scheme is 31 October 2025.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/fweh4rnt/wearables.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52f0c30110"/>
                </item>
                <item>
                    <title>ABPI launches manifesto to make Scotland a leader in R&amp;D and cutting-edge medicines</title>
<link>https://www.abpi.org.uk/media/news/2025/september/abpi-launches-manifesto-to-make-scotland-a-leader-in-rd-and-cutting-edge-medicines/</link>                    <pubDate>Wed, 01 Jul 2026 12:29:41 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Scotland]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/september/abpi-launches-manifesto-to-make-scotland-a-leader-in-rd-and-cutting-edge-medicines/</guid>
                    <description><![CDATA[The ABPI has launched its manifesto for the next Scottish Government, calling for urgent action to unlock Scotland&#x2019;s full potential as a partner of choice for life sciences and health innovation.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/jcgofh1n/women-scientist-microscope-871x581-webp75.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef19bde0"/>
                </item>
                <item>
                    <title>Companies granted further extension to VPAG 2026 decision deadline</title>
<link>https://www.abpi.org.uk/media/news/2025/october/companies-granted-further-extension-to-vpag-2026-decision-deadline/</link>                    <pubDate>Wed, 01 Jul 2026 12:29:41 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Statutory Scheme]]></category>
                            <category><![CDATA[VPAG]]></category>
                            <category><![CDATA[VPAG (1)]]></category>
                            <category><![CDATA[Voluntary Scheme]]></category>
                            <category><![CDATA[Voluntary Scheme News]]></category>
                            <category><![CDATA[Pricing]]></category>
                            <category><![CDATA[Access]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/october/companies-granted-further-extension-to-vpag-2026-decision-deadline/</guid>
                    <description><![CDATA[The ABPI and the government have agreed to a further two-week extension to the deadline by which companies must give notice if they intend to leave the 2024 voluntary scheme for branded medicines pricing, access and growth (VPAG). ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/fweh4rnt/wearables.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52f0c30110"/>
                </item>
                <item>
                    <title>Scotland&#x27;s life sciences strategy is a welcome vision that must be matched with delivery, says ABPI</title>
<link>https://www.abpi.org.uk/media/news/2025/november/scotlands-life-sciences-strategy-is-a-welcome-vision-that-must-be-matched-with-delivery-says-abpi/</link>                    <pubDate>Wed, 01 Jul 2026 12:29:41 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Scotland]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/november/scotlands-life-sciences-strategy-is-a-welcome-vision-that-must-be-matched-with-delivery-says-abpi/</guid>
                    <description><![CDATA[The Strategy aims to create the most effective environment for developing, testing, manufacturing and commercialising life sciences innovation. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/hmibbi0s/biochemical-research-580x405-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eea1a7b0"/>
                </item>
                <item>
                    <title>Companies granted third extension to VPAG 2026 decision deadline &#x2013; now set for 16 December</title>
<link>https://www.abpi.org.uk/media/news/2025/november/companies-granted-third-extension-to-vpag-2026-decision-deadline-now-set-for-16-december/</link>                    <pubDate>Wed, 01 Jul 2026 12:29:40 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[VPAG]]></category>
                            <category><![CDATA[VPAG (1)]]></category>
                            <category><![CDATA[Voluntary Scheme]]></category>
                            <category><![CDATA[Voluntary Scheme News]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/november/companies-granted-third-extension-to-vpag-2026-decision-deadline-now-set-for-16-december/</guid>
                    <description><![CDATA[The ABPI and the government have agreed to a further extension to the deadline by which companies must give notice if they intend to leave the 2024 voluntary scheme for branded medicines pricing, access and growth (VPAG). The revised deadline for submitting notice to leave the VPAG scheme is now 16 December 2025.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/fweh4rnt/wearables.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52f0c30110"/>
                </item>
                <item>
                    <title>ABPI calls for Budget action to revive UK life sciences investment</title>
<link>https://www.abpi.org.uk/media/news/2025/november/abpi-calls-for-budget-action-to-revive-uk-life-sciences-investment/</link>                    <pubDate>Wed, 01 Jul 2026 12:29:40 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Budget]]></category>
                            <category><![CDATA[Access]]></category>
                            <category><![CDATA[Economy and Industry]]></category>
                            <category><![CDATA[Health and Access to Medicines]]></category>
                            <category><![CDATA[Life Sciences]]></category>
                            <category><![CDATA[MHRA]]></category>
                            <category><![CDATA[NICE]]></category>
                            <category><![CDATA[Pricing]]></category>
                            <category><![CDATA[Research and Development]]></category>
                            <category><![CDATA[Science and innovation]]></category>
                            <category><![CDATA[Voluntary Scheme]]></category>
                            <category><![CDATA[VPAG]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/november/abpi-calls-for-budget-action-to-revive-uk-life-sciences-investment/</guid>
                    <description><![CDATA[The ABPI has used its pre-Budget submission to urge the government to take urgent steps to reverse a decade-long decline in investment and restore the UK&#x2019;s position as a global leader in life sciences. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/0mgjexoi/mps-2-871x581.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d9da41cdf42800"/>
                </item>
                <item>
                    <title>UK-India trade agreement does not support UK life sciences ambitions, says ABPI</title>
<link>https://www.abpi.org.uk/media/news/2025/may/uk-india-trade-agreement-does-not-support-uk-life-sciences-ambitions-says-abpi/</link>                    <pubDate>Wed, 01 Jul 2026 12:29:40 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[International]]></category>
                            <category><![CDATA[Intellectual Property]]></category>
                            <category><![CDATA[Economy and Industry]]></category>
                            <category><![CDATA[Free Trade Agreements]]></category>
                            <category><![CDATA[G7]]></category>
                            <category><![CDATA[Trade]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/may/uk-india-trade-agreement-does-not-support-uk-life-sciences-ambitions-says-abpi/</guid>
                    <description><![CDATA[The ABPI is disappointed that the deal does not appear to address longstanding industry concerns about intellectual property protections for UK life science innovators within the Indian market, particularly the need for regulatory data protection. This will prevent our sector from realising the true potential of this deal. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/dbhj0cp5/pexels-tom-fisk-3063470.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1da27881f8f4710"/>
                </item>
                <item>
                    <title>ABPI comment on UK-US trade agreement</title>
<link>https://www.abpi.org.uk/media/news/2025/may/abpi-comment-on-uk-us-trade-agreement/</link>                    <pubDate>Wed, 01 Jul 2026 12:29:39 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[International]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/may/abpi-comment-on-uk-us-trade-agreement/</guid>
                    <description><![CDATA[The UK government has announced a trade agreement with the US.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/uashznt5/hands-agreement-580x405-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eed19150"/>
                </item>
                <item>
                    <title>Novo Nordisk ABPI membership restored</title>
<link>https://www.abpi.org.uk/media/news/2025/march/novo-nordisk-abpi-membership-restored/</link>                    <pubDate>Wed, 01 Jul 2026 12:29:39 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[PMCPA]]></category>
                            <category><![CDATA[Regulatory]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/march/novo-nordisk-abpi-membership-restored/</guid>
                    <description><![CDATA[Novo Nordisk&#x2019;s two-year suspension from the Association of the British Pharmaceutical Industry (ABPI) for serious breaches of the ABPI Code of Practice has come to an end.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/vhxbspk4/vial-pipette-purple-871x581.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef5ce160"/>
                </item>
                <item>
                    <title>Medicine levy makes the UK un-investable, say pharma leaders</title>
<link>https://www.abpi.org.uk/media/news/2025/march/medicine-levy-makes-the-uk-un-investable-say-pharma-leaders/</link>                    <pubDate>Wed, 01 Jul 2026 12:29:39 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Access]]></category>
                            <category><![CDATA[Medicines sales]]></category>
                            <category><![CDATA[Pricing]]></category>
                            <category><![CDATA[Statutory Scheme]]></category>
                            <category><![CDATA[Value]]></category>
                            <category><![CDATA[Voluntary Scheme]]></category>
                            <category><![CDATA[Voluntary Scheme News]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/march/medicine-levy-makes-the-uk-un-investable-say-pharma-leaders/</guid>
                    <description><![CDATA[Leaders from across a key growth sector for the government&#x2019;s upcoming industrial strategy say future UK investment is unlikely unless an unsustainable levy on manufacturers is addressed.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/wqxdl050/brown-bottle-fill-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef7af0b0"/>
                </item>
                <item>
                    <title>ABPI welcomes new MHRA Chief Executive Officer</title>
<link>https://www.abpi.org.uk/media/news/2025/march/abpi-welcomes-new-mhra-chief-executive-officer/</link>                    <pubDate>Wed, 01 Jul 2026 12:29:38 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Regulatory]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/march/abpi-welcomes-new-mhra-chief-executive-officer/</guid>
                    <description><![CDATA[Lawrence Tallon has been named as the new Chief Executive Officer of Medicines and Healthcare products Regulatory Agency (MHRA).]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/d3gp0fba/capsules-clear-blister-871x581.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef5a4950"/>
                </item>
                <item>
                    <title>UK doubles statutory payment rate on pharmaceutical sales from July</title>
<link>https://www.abpi.org.uk/media/news/2025/june/uk-doubles-statutory-payment-rate-on-pharmaceutical-sales-from-july/</link>                    <pubDate>Wed, 01 Jul 2026 12:29:38 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Statutory Scheme]]></category>
                            <category><![CDATA[Voluntary Scheme]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/june/uk-doubles-statutory-payment-rate-on-pharmaceutical-sales-from-july/</guid>
                    <description><![CDATA[The UK government has doubled the rate that pharmaceutical companies must repay on the sales of newer products to the NHS under the statutory scheme for branded medicines in the second half of 2025, to a record 31.3 per cent.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/ujpcz05h/records-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52f0369f90"/>
                </item>
                <item>
                    <title>The UK must act to stem &#xA3;11 billion loss to health research</title>
<link>https://www.abpi.org.uk/media/news/2025/june/the-uk-must-act-to-stem-11-billion-loss-to-health-research/</link>                    <pubDate>Wed, 01 Jul 2026 12:29:38 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Access]]></category>
                            <category><![CDATA[Health and Access to Medicines]]></category>
                            <category><![CDATA[Medicines sales]]></category>
                            <category><![CDATA[Pricing]]></category>
                            <category><![CDATA[Value]]></category>
                            <category><![CDATA[Voluntary Scheme]]></category>
                            <category><![CDATA[Voluntary Scheme News]]></category>
                            <category><![CDATA[VPAG]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/june/the-uk-must-act-to-stem-11-billion-loss-to-health-research/</guid>
                    <description><![CDATA[The UK could lose out on &#xA3;11bn in pharmaceuticals research and development (R&amp;D) investment by 2033, and see fewer new medicine launches in the NHS, unless very high and unpredictable medicines sales clawbacks are addressed, according to WPI Economics.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/5mxhyzbe/genetics-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52f025d6b0"/>
                </item>
                <item>
                    <title>Publication of A Common Understanding 2025</title>
<link>https://www.abpi.org.uk/media/news/2025/july/publication-of-a-common-understanding-2025/</link>                    <pubDate>Wed, 01 Jul 2026 12:29:37 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Partnership]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/july/publication-of-a-common-understanding-2025/</guid>
                    <description><![CDATA[The Common Understanding 2025 publication demonstrates the value of productive relationships between the pharmaceutical industry and other partners in Scotland. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/wzqj5vnu/careers-support-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52efafbc50"/>
                </item>
                <item>
                    <title>Modernising UK homecare will boost neighbourhood health services and save money, says ABPI</title>
<link>https://www.abpi.org.uk/media/news/2025/july/modernising-uk-homecare-will-boost-neighbourhood-health-services-and-save-money-says-abpi/</link>                    <pubDate>Wed, 01 Jul 2026 12:29:37 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Homecare]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/july/modernising-uk-homecare-will-boost-neighbourhood-health-services-and-save-money-says-abpi/</guid>
                    <description><![CDATA[The UK&#x2019;s homecare service potentially saves the NHS &#xA3;1.67 billion a year, and has the potential to save significantly more through shifting care from hospitals and into patients&#x2019; homes.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/pglfbcdf/nurse-patient-hands-871x581.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef4c1880"/>
                </item>
                <item>
                    <title>Equitable access to medicines and vaccines essential for patient safety and outcomes, says ABPI</title>
<link>https://www.abpi.org.uk/media/news/2025/july/equitable-access-to-medicines-and-vaccines-essential-for-patient-safety-and-outcomes-says-abpi/</link>                    <pubDate>Wed, 01 Jul 2026 12:29:36 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Safety]]></category>
                            <category><![CDATA[Supply]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/july/equitable-access-to-medicines-and-vaccines-essential-for-patient-safety-and-outcomes-says-abpi/</guid>
                    <description><![CDATA[The Dash Review has warned that poor or inconsistent access to appropriate treatment is a patient safety issue. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/jihl0ma0/wheelchair-professional-871x581-webp75.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eeebf720"/>
                </item>
                <item>
                    <title>ABPI response to the Chancellor&#x2019;s Davos speech on attracting talent for UK growth sectors</title>
<link>https://www.abpi.org.uk/media/news/2025/january/abpi-response-to-the-chancellor-s-davos-speech-on-attracting-talent-for-uk-growth-sectors/</link>                    <pubDate>Wed, 01 Jul 2026 12:29:14 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Skills]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/january/abpi-response-to-the-chancellor-s-davos-speech-on-attracting-talent-for-uk-growth-sectors/</guid>
                    <description><![CDATA[The UK will look to secure the world&#x2019;s top talent in key growth sectors.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/1qsnrrpa/international-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52efb8e410"/>
                </item>
                <item>
                    <title>VPAG payment rate for newer medicines will be 14.5% in 2026</title>
<link>https://www.abpi.org.uk/media/news/2025/december/vpag-payment-rate-for-newer-medicines-will-be-145-in-2026/</link>                    <pubDate>Wed, 01 Jul 2026 12:29:14 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[VPAG]]></category>
                            <category><![CDATA[VPAG (1)]]></category>
                            <category><![CDATA[Access]]></category>
                            <category><![CDATA[Life Sciences]]></category>
                            <category><![CDATA[Medicines sales]]></category>
                            <category><![CDATA[Pricing]]></category>
                            <category><![CDATA[Statutory Scheme]]></category>
                            <category><![CDATA[Voluntary Scheme]]></category>
                            <category><![CDATA[Voluntary Scheme News]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/december/vpag-payment-rate-for-newer-medicines-will-be-145-in-2026/</guid>
                    <description><![CDATA[The government has announced that the 2026 payment rate for newer medicines under the Voluntary Scheme for Branded Medicines Pricing and Access (VPAG) will be 14.5 per cent, down from a record 22.5 per cent in 2025. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/qcmp1kqt/statistics-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52f01275c0"/>
                </item>
                <item>
                    <title>UK-US deal is good news for NHS patients and will help to support UK life sciences competitiveness, says ABPI</title>
<link>https://www.abpi.org.uk/media/news/2025/december/uk-us-deal-is-good-news-for-nhs-patients-and-will-help-to-support-uk-life-sciences-competitiveness-says-abpi/</link>                    <pubDate>Wed, 01 Jul 2026 12:29:13 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Commercial]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/december/uk-us-deal-is-good-news-for-nhs-patients-and-will-help-to-support-uk-life-sciences-competitiveness-says-abpi/</guid>
                    <description><![CDATA[Industry hopes the new trade agreement will allow more innovative medicines to reach a greater number of NHS patients and will be a positive step in supporting the UK life sciences industry. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/yheezl41/doctor-consult-bed-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef31b2b0"/>
                </item>
                <item>
                    <title>Decline in commercial clinical trial recruitment selling patients short, says ABPI</title>
<link>https://www.abpi.org.uk/media/news/2025/december/decline-in-commercial-clinical-trial-recruitment-selling-patients-short-says-abpi/</link>                    <pubDate>Wed, 01 Jul 2026 12:29:13 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Clinical research]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/december/decline-in-commercial-clinical-trial-recruitment-selling-patients-short-says-abpi/</guid>
                    <description><![CDATA[The low number of patients recruited, together with slow set-up times, is raising costs and lowering the efficiency of industry clinical trials in the UK. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/pgwagn03/doctor-patient-bedside-871x581-web75.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eefc4ad0"/>
                </item>
                <item>
                    <title>Time to emphasise the economics in health economics</title>
<link>https://www.abpi.org.uk/media/blogs/2026/january/time-to-emphasise-the-economics-in-health-economics/</link>                    <pubDate>Wed, 01 Jul 2026 12:29:02 GMT</pubDate>
                            <dc:creator><![CDATA[Victoria Jordan]]></dc:creator>
                            <category><![CDATA[Access]]></category>
                            <category><![CDATA[Economy and Industry]]></category>
                            <category><![CDATA[NICE]]></category>
                            <category><![CDATA[NICE Methods Review]]></category>
                            <category><![CDATA[Pricing]]></category>
                            <category><![CDATA[Value]]></category>
                            <category><![CDATA[Voluntary Scheme]]></category>
                            <category><![CDATA[VPAG]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2026/january/time-to-emphasise-the-economics-in-health-economics/</guid>
                    <description><![CDATA[Victoria Jordan, ABPI Value and Access Policy Director, discusses the Health Economics of the UK-US Economic Prosperity Deal and the commitment to increase NICE&#x27;s baseline threshold use, the first change since its introduction in the early 2000s.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/34lnw2yz/two-scientists-vial-871x581.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c978d897e40"/>
                </item>
                <item>
                    <title>Equity in the age of advanced therapies: insights from haemophilia</title>
<link>https://www.abpi.org.uk/media/blogs/2026/february/equity-in-the-age-of-advanced-therapies-insights-from-haemophilia/</link>                    <pubDate>Wed, 01 Jul 2026 12:29:01 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2026/february/equity-in-the-age-of-advanced-therapies-insights-from-haemophilia/</guid>
                    <description><![CDATA[In Laurence Woollard&#x27;s latest blog for Rare Disease Day, he reflects on how advanced therapies are being introduced within the NHS &#x2013; highlighting the need for a Patient Charter. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/oqsek0un/laurence-woollard.png?width=240&amp;height=135&amp;quality=90&amp;v=1dca67f1e14a880"/>
                </item>
                <item>
                    <title>Accelerated review of VPAG concludes without agreement</title>
<link>https://www.abpi.org.uk/media/news/2025/august/accelerated-review-of-vpag-concludes-without-agreement/</link>                    <pubDate>Thu, 04 Jun 2026 18:44:30 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/august/accelerated-review-of-vpag-concludes-without-agreement/</guid>
                    <description><![CDATA[The ABPI can confirm that industry and government have been unable to reach an agreement on changes to a controversial medicines payment scheme which is undermining UK patient access to innovative medicines and the competitiveness of the UK life sciences industry.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/wqxdl050/brown-bottle-fill-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef7af0b0"/>
                </item>
                <item>
                    <title>What drives company decisions on new medicine launches and UK investment?</title>
<link>https://www.abpi.org.uk/media/blogs/2026/january/what-drives-company-decisions-on-new-medicine-launches-and-uk-investment/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:31 GMT</pubDate>
                            <category><![CDATA[Access]]></category>
                            <category><![CDATA[Health and Access to Medicines]]></category>
                            <category><![CDATA[Medicines sales]]></category>
                            <category><![CDATA[NICE]]></category>
                            <category><![CDATA[Pricing]]></category>
                            <category><![CDATA[Statutory Scheme]]></category>
                            <category><![CDATA[Value]]></category>
                            <category><![CDATA[Voluntary Scheme]]></category>
                            <category><![CDATA[Voluntary Scheme News]]></category>
                            <category><![CDATA[VPAG]]></category>
                            <category><![CDATA[VPAG (1)]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2026/january/what-drives-company-decisions-on-new-medicine-launches-and-uk-investment/</guid>
                    <description><![CDATA[In this piece, David Watson, ABPI Executive Director of Patient Access, discusses the findings of ABPI&#x27;s 2025 Medicines Impact and Investment Survey, which aims to supplement existing data to understand and track how UK policy conditions influence company decisions, particularly on investment, workforce plans, and prioritisation of medicines launches. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/34lnw2yz/two-scientists-vial-871x581.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c978d897e40"/>
                </item>
                <item>
                    <title>Building momentum through the VPAG review</title>
<link>https://www.abpi.org.uk/media/blogs/2026/february/building-momentum-through-the-vpag-review/</link>                    <pubDate>Tue, 31 Mar 2026 14:02:29 GMT</pubDate>
                            <dc:creator><![CDATA[Pinchas Kahtan]]></dc:creator>
                            <category><![CDATA[Access]]></category>
                            <category><![CDATA[Medicines sales]]></category>
                            <category><![CDATA[Voluntary Scheme]]></category>
                            <category><![CDATA[Voluntary Scheme News]]></category>
                            <category><![CDATA[VPAG]]></category>
                            <category><![CDATA[VPAG (1)]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/blogs/2026/february/building-momentum-through-the-vpag-review/</guid>
                    <description><![CDATA[The latest Operational Review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access and Growth (VPAG) took place in late December. In this piece, Pinchas Kahtan, ABPI&#x27;s Head of Commercial Policy, shares the key points discussed and agreed at the meeting, and looks ahead to what&#x27;s next for 2026.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/rszec1xe/compensation-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52efe74710"/>
                </item>
                <item>
                    <title>Attracting global talent is key to UK Life Sciences success</title>
<link>https://www.abpi.org.uk/media/news/2025/october/attracting-global-talent-is-key-to-uk-life-sciences-success/</link>                    <pubDate>Thu, 13 Nov 2025 17:57:15 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/october/attracting-global-talent-is-key-to-uk-life-sciences-success/</guid>
                    <description><![CDATA[If the UK is to become Europe&#x2019;s leading life sciences economy by 2030, it must sharpen its global appeal and do more to attract and keep world-class talent.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/2dkbtonm/chemist-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52f01c12b0"/>
                </item>
                <item>
                    <title>UK life sciences plan falls short, says ABPI</title>
<link>https://www.abpi.org.uk/media/news/2025/july/uk-life-sciences-plan-falls-short-says-abpi/</link>                    <pubDate>Wed, 16 Jul 2025 08:25:29 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/july/uk-life-sciences-plan-falls-short-says-abpi/</guid>
                    <description><![CDATA[The ABPI is warning that the core ambition of the government&#x27;s new life sciences strategy will not be realised unless it makes a real commitment to invest more in new medicines. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/dkmh2k31/microscope-laptop-580x405-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eec7cd50"/>
                </item>
                <item>
                    <title>ABPI response to NHS 10-Year Health Plan</title>
<link>https://www.abpi.org.uk/media/news/2025/july/abpi-response-to-nhs-10-year-health-plan/</link>                    <pubDate>Thu, 03 Jul 2025 12:45:18 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[NHS]]></category>
                            <category><![CDATA[Access]]></category>
                            <category><![CDATA[Genomics]]></category>
                            <category><![CDATA[Innovation]]></category>
                            <category><![CDATA[NICE]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/july/abpi-response-to-nhs-10-year-health-plan/</guid>
                    <description><![CDATA[The NHS 10-Year Health Plan gets it right on genomics and advanced therapies, as well as accelerated clinical trials and supporting participation in research. However, innovative medicines could play a far greater role in revolutionising healthcare. The plan also sends a worrying signal about limiting patient and doctor choices around the best treatment for them.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/pnafsqgg/doctor-patient-detail-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eee25a30"/>
                </item>
                <item>
                    <title>ABPI response to the new Industrial Strategy</title>
<link>https://www.abpi.org.uk/media/news/2025/june/abpi-response-to-the-new-industrial-strategy/</link>                    <pubDate>Mon, 23 Jun 2025 09:50:40 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/june/abpi-response-to-the-new-industrial-strategy/</guid>
                    <description><![CDATA[The government&#x2019;s new Industrial Strategy reaffirms its commitment to growing the economy. The key test for life sciences will be whether it can return the UK to international competitiveness.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/2mzleyni/white-tablet-factory-871x581.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef7d61b0"/>
                </item>
                <item>
                    <title>Coalition calls for roadmap to improve inclusivity in clinical research</title>
<link>https://www.abpi.org.uk/media/news/2025/june/coalition-calls-for-roadmap-to-improve-inclusivity-in-clinical-research/</link>                    <pubDate>Wed, 11 Jun 2025 23:08:38 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/june/coalition-calls-for-roadmap-to-improve-inclusivity-in-clinical-research/</guid>
                    <description><![CDATA[Encouraging participation of a wide range of diverse communities in clinical research is essential to make sure that innovative medicines meet the needs of the people they are intended for, says a new report from ABPI and AMRC. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/21zjbgkf/doctor-patient-talk-871x581.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d9af1fa473a6b0"/>
                </item>
                <item>
                    <title>Spending Review &#x2013; NHS must invest more in proven innovations, says ABPI</title>
<link>https://www.abpi.org.uk/media/news/2025/june/spending-review-nhs-must-invest-more-in-proven-innovations-says-abpi/</link>                    <pubDate>Wed, 11 Jun 2025 13:19:16 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Budget]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/june/spending-review-nhs-must-invest-more-in-proven-innovations-says-abpi/</guid>
                    <description><![CDATA[The government spending review has concluded with a 3% per year increase for health and the NHS. As part of fixing the broken NHS, the innovative pharmaceutical industry is calling for greater focus to be put on investing in those areas of health spending that have the strongest evidence for both value for money and for directly improving patient outcomes.&#xA;]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/l5lb4t5p/mps-871x581.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d9da41cdd52e50"/>
                </item>
                <item>
                    <title>ABPI welcomes announcement of ten-year budgets for R&amp;D funding</title>
<link>https://www.abpi.org.uk/media/news/2025/may/abpi-welcomes-announcement-of-ten-year-budgets-for-rd-funding/</link>                    <pubDate>Mon, 19 May 2025 13:24:52 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Research and Development]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/may/abpi-welcomes-announcement-of-ten-year-budgets-for-rd-funding/</guid>
                    <description><![CDATA[The Department for Science, Innovation and Technology (DSIT) today announced new ten-year budgets for science funding. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/hmibbi0s/biochemical-research-580x405-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eea1a7b0"/>
                </item>
                <item>
                    <title>Life sciences growth requires payment rates to return to internationally comparable levels</title>
<link>https://www.abpi.org.uk/media/news/2025/may/life-sciences-growth-requires-payment-rates-to-return-to-internationally-comparable-levels/</link>                    <pubDate>Wed, 07 May 2025 23:01:43 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Access]]></category>
                            <category><![CDATA[Medicines sales]]></category>
                            <category><![CDATA[Pricing]]></category>
                            <category><![CDATA[Statutory Scheme]]></category>
                            <category><![CDATA[Value]]></category>
                            <category><![CDATA[Voluntary Scheme]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/may/life-sciences-growth-requires-payment-rates-to-return-to-internationally-comparable-levels/</guid>
                    <description><![CDATA[Existing and proposed medicine payment rates of a quarter to a third of UK pharmaceutical company revenue are incompatible with government ambitions to grow the sector.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/v31prhfs/doctor-woman-watch-871x581.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef1c55f0"/>
                </item>
                <item>
                    <title>ABPI comment on 2025 VPAG rates of 22.9%</title>
<link>https://www.abpi.org.uk/media/news/2025/january/abpi-comment-on-2025-vpag-rates-of-229/</link>                    <pubDate>Tue, 06 May 2025 16:01:49 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Voluntary Scheme]]></category>
                            <category><![CDATA[Voluntary Scheme News]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/january/abpi-comment-on-2025-vpag-rates-of-229/</guid>
                    <description><![CDATA[The Voluntary Scheme for Branded Medicines Pricing and Access (VPAG) payment rate for newer medicines has been set at 22.9% in 2025, well above expectations, putting UK industry growth and investment at risk. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/nncpaw0e/pharmacist-medicines-shelves-580x405-1-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eec13da0"/>
                </item>
                <item>
                    <title>Industry/academia links fuel UK medical innovation</title>
<link>https://www.abpi.org.uk/media/news/2025/february/industryacademia-links-fuel-uk-medical-innovation/</link>                    <pubDate>Tue, 06 May 2025 15:58:17 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/february/industryacademia-links-fuel-uk-medical-innovation/</guid>
                    <description><![CDATA[As National Apprenticeship Week (10 - 14 February) begins, new figures highlight the growing importance of industry-academic partnerships in filling skills gaps, advancing research, and keeping the UK ahead in global life sciences innovation.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/zvpilozj/adobestock_536708880.jpeg?width=240&amp;height=135&amp;quality=90&amp;v=1daef1669a41190"/>
                </item>
                <item>
                    <title>UK set to demand a third of pharmaceutical company revenue in second half of 2025</title>
<link>https://www.abpi.org.uk/media/news/2025/march/uk-set-to-demand-a-third-of-pharmaceutical-company-revenue-in-second-half-of-2025/</link>                    <pubDate>Tue, 06 May 2025 15:53:27 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Medicines sales]]></category>
                            <category><![CDATA[Pricing]]></category>
                            <category><![CDATA[Statutory Scheme]]></category>
                            <category><![CDATA[Voluntary Scheme]]></category>
                            <category><![CDATA[Voluntary Scheme News]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/march/uk-set-to-demand-a-third-of-pharmaceutical-company-revenue-in-second-half-of-2025/</guid>
                    <description><![CDATA[The government is proposing to raise the Statutory Scheme payment rate for newer branded medicines from 15.5% to 32.2% of subject companies&#x27; NHS sales in the second half of 2025.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/ujpcz05h/records-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52f0369f90"/>
                </item>
                <item>
                    <title>Delivering the NHS 10-Year Plan will require a fourth &#x2018;shift&#x2019; says ABPI</title>
<link>https://www.abpi.org.uk/media/news/2025/march/delivering-the-nhs-10-year-plan-will-require-a-fourth-shift-says-abpi/</link>                    <pubDate>Tue, 06 May 2025 15:51:41 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[NHS]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/march/delivering-the-nhs-10-year-plan-will-require-a-fourth-shift-says-abpi/</guid>
                    <description><![CDATA[Creating an NHS fit for the future will mean investing in innovative medicines and vaccines to transform people&#x2019;s lives. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/pgwagn03/doctor-patient-bedside-871x581-web75.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eefc4ad0"/>
                </item>
                <item>
                    <title>ABPI response to DSIT spending allocations</title>
<link>https://www.abpi.org.uk/media/news/2025/april/abpi-response-to-dsit-spending-allocations/</link>                    <pubDate>Tue, 06 May 2025 15:46:29 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/april/abpi-response-to-dsit-spending-allocations/</guid>
                    <description><![CDATA[The Department for Science, Innovation and Technology (DSIT) has today announced funding for research and development, including in life sciences. ]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/25rae34u/two-scientists-tube-871x581.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52ef584d80"/>
                </item>
                <item>
                    <title>Russell Abberley confirmed as ABPI President-elect</title>
<link>https://www.abpi.org.uk/media/news/2025/april/russell-abberley-confirmed-as-abpi-president-elect/</link>                    <pubDate>Tue, 06 May 2025 14:45:18 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/april/russell-abberley-confirmed-as-abpi-president-elect/</guid>
                    <description><![CDATA[Russell Abberley, Vice President and General Manager of Amgen UK and Ireland, has been confirmed as ABPI President-elect]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/3wil3jtu/russell_abberley_actingabpi_president.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1dbaa455d524660"/>
                </item>
                <item>
                    <title>ABPI response to Prime Minister&#x27;s announcement on support for medical research</title>
<link>https://www.abpi.org.uk/media/news/2025/april/abpi-response-to-prime-ministers-announcement-on-support-for-medical-research/</link>                    <pubDate>Tue, 08 Apr 2025 10:23:41 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Health data]]></category>
                            <category><![CDATA[Clinical research]]></category>
                            <category><![CDATA[Research and Development]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/april/abpi-response-to-prime-ministers-announcement-on-support-for-medical-research/</guid>
                    <description><![CDATA[The Prime Minister has announced new funding and ambitious targets for UK&#xA0;medical research today (7 April).&#xA0;&#xA0;]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/qyofdl1v/computational-871x581-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52f044d060"/>
                </item>
                <item>
                    <title>The government and ABPI agree to accelerate a planned review of VPAG</title>
<link>https://www.abpi.org.uk/media/news/2025/april/the-government-and-abpi-agree-to-accelerate-a-planned-review-of-vpag/</link>                    <pubDate>Fri, 04 Apr 2025 16:00:53 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Voluntary Scheme]]></category>
                            <category><![CDATA[Voluntary Scheme News]]></category>
                            <category><![CDATA[Pricing]]></category>
                            <category><![CDATA[Access]]></category>
                            <category><![CDATA[Statutory Scheme]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/april/the-government-and-abpi-agree-to-accelerate-a-planned-review-of-vpag/</guid>
                    <description><![CDATA[A planned autumn review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG) will be brought forward to report back in June.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/ptvdrsdy/data-laptop-patient-580x405-1-webp60.webp?width=240&amp;height=135&amp;quality=90&amp;v=1d96c52eed40250"/>
                </item>
                <item>
                    <title>NHS data infrastructure must support the research needs of the life sciences sector</title>
<link>https://www.abpi.org.uk/media/news/2025/february/nhs-data-infrastructure-must-support-the-research-needs-of-the-life-sciences-sector/</link>                    <pubDate>Wed, 02 Apr 2025 12:42:47 GMT</pubDate>
                            <dc:creator><![CDATA[Press Office]]></dc:creator>
                            <category><![CDATA[Health data]]></category>
                    <guid isPermaLink="false">https://www.abpi.org.uk/media/news/2025/february/nhs-data-infrastructure-must-support-the-research-needs-of-the-life-sciences-sector/</guid>
                    <description><![CDATA[Co-designing new networks with research users is critical to delivering the full scientific and commercial value of NHS health data.]]></description>
                    <media:thumbnail width="240" height="135" url="https://www.abpi.org.uk/media/l0xf1lgz/scientist-pink-background-2025-871x581.jpg?width=240&amp;height=135&amp;quality=90&amp;v=1db81eb91909170"/>
                </item>
    </channel>
</rss>

